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ABSTRACT
IgLONsare cell adhesion molecules which belong to the Ig superfamily.
They are thoughtto play a role in the development of the nervous system. There are
four members in the group; CEPU-1, OBCAM, LAMP and Neurotractin; they are
expressed inside and outside the nervous system and increase with the development.
IgLONsare formed of three Ig domains that are attached to lipid rafts within the cell
membrane by a GPI anchor.
Previous experiments suggested that single transfected Ig_LON-CHOcells fail
to inhibit neurite outgrowth while double transfected cell lines do. It is proposed that
IgLONsinteractin the plane of the membrane as dimeric IgLONs (DigLONs).
To investigate the role of DigLONs, CEPU-OBCAM-Fcrecombinantprotein
(CO-FC)was generated. CEPU- Fe waslabelled with a V5 tag and OBCAM-Fc with
a myctag allowing characterisation by ELISA assays with both anti-V5 and anti-myc
antibodies. Stable doubly transfected CHO cells secreted a mixture of CO-Fc
heterodimeric, O-O-Fc and C-C-Fe homodimeric proteins. Therfore, anti-myc
antibody will be used in detection of CO-Fc; however, OO-Fc will be detected.
CO-Fc inhibits the initiation of neurite outgrowth from E8 forebrain neurons
whenusedas a substrate whereas no inhibition occurred with CEPU-Fc or OBCAM-
Fe alone. Immunofluorescence studies show that CO-Fc recombinantprotein bindsto
the surface of the E8 chick forebrain, E10 DRG and sympathetic neurons using anti
myc antibody. Treatment of forebrain neurons with PI-PLC, to remove GPI anchored
glycoproteins including IgLONsresults in a loss of binding of CO-Fc to the neuronal
cell surface. In addition, the inhibition of neurite outgrowth from E8 forebrain
neurons reversed after PI-PLC treatment. All these evidences suggested that IZLON
might be the putative receptor, or a part of complex with a transmembranereceptor.
Previously, E10 dorsal root ganglion neurons (DRG) and sympathetic
neuronal growth wasnot inhibited by the CO doubly transfected cell line, while no
inhibition occurred with the concentration that used with forebrain neurons.
However, higher concentration of CO-Fc (4xfold) significantly inhibits the neurite
outgrowth from both neurons. CO-Fe was tested on IgLON transfected CHO cell
lines to elucidate the role of IgLONs in the CEPU-OBCAM putative receptor
complex.It interacts with LAMP-CHO, CEPU-CHO, OBCAM-CHOand CL-CHO
cells but, there was no interaction with CO-CHOcells. In E18 chick retina frozen
section, CO-Fc bindsto the outer plexiform layer ofthe retina.
A prelimanary fluorescence resonance energy transfer (FRET) experiment
wascarried out to distinguish between the CO-Fc heterodimerthat is labelled with
both myc and V5 tags from the mixture of OO-Fe which is only labelled with myc
tag or CC-Fe whichis labelled by V5 tag. A positive control was generated whichis
OO-myc recombinat protein detected with anti-myc Alexa fluor 555(acceptor) and
AlexaFluor 488 (donor) antibodies on LAMP-CHOcells. The FRET ratio between
the fluorphores was about 20 %.
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Chapter One
Introduction
Developmentof the nervous system:
Life starts as a single fertilised egg or a zygote which theninitially divides into
many undifferentiated cells. These cells will form eventually, a structure called a
blastula which has an openingcalled a blastopore. Gastrulation is a movementof the
primitive cells (gastrula) through an opening called a blastopore. The gastrula has
three layers; the outer is ectoderm followed by mesoderm and the inner is the
endoderm (Leptin, 2005; Solnica-Krezel, 2005).
In the dorsal ectoderm,a flat dish-shaped area invaginates at the centre to form
the neural plate and then closes to form the neural tube, which is the origin of the
central nervous system (Munoz-Sanjuan and Brivanlou, 2002). The floor plate is a
transient structure that originates from the mesoderm. A structure lies below the
neural tube called the notochord which derives from the mesoderm (Placzek etal.,
1990; Stemple, 2005). Some of the cells above the neural tube migrate away to form
the neural crest, whereas somites lie beside the neural tube (Wilson and Maden,
2005). At the bottom of the neural tube is an area called the floorplate while at the
top is the roof plate (Lee et al., 2000). The anterior end of the neural tube forms the
forebrain which develops into the telencephalon and the diencephalon, whereas the
posterior part forms the midbrain, hindbrain and spinal cord. After the gastrulation
stage, the neurulation stage starts with migration of neural crest cells to form
sympathetic ganglia, sensory (dorsal root) ganglia and Schwann cells and other
structures (figure 1.1).
There are four molecules that are particularly important for the developmentof
the central nervous system, fibroblast growth factors (FGF), Sonic hedgehog (SHH),
Bone morphogenic protein (BMP) and retinoic acid (Wilson and Maden, 2005).
There is evidence of the importance of these molecules as destruction of the
notochord leads to malformation of floorplate. Whereas addition of another
notochord by grafting result in induction of extra floor plates and motor neurons
(Placzeket al., 1990; Yamadaetal., 1991)
Important secreted molecules in development of CNS:
From Notochord andfloor plate:
Sonic hedgehog (SHH):
Sonic hedgehogis a signaling molecule that is secreted by the notochord and
floor plate. Sonic hedgehogis essential for the floor plate development (Placzek et
al., 1990; Stemple, 2005). The inactivation of SHH either by antibody or blocking its
geneled to failure of induction of floor plate. Furthermore, increased expression of
SHHled to increased induction of skeletal muscle, skin and vertebrae (Wilson and
Maden, 2005), floor plate and motor neurons (Marti et al., 1995). SHH plays an
essential role in specification of the motor neurons and interneurons(Ericsonetal.,
1997; Ericson et al., 1996).
Other experiments demonstrated that the induction of floor plate cells and
motor neurons depends on the precise concentration of the SHH (Roelink etal.,
1995). High level expression of SHH inducesthe floor plate, whilst the ventral motor
neurons are induced at lower concentrations by activation of specific homeodomain
transcription factors which are components responsible for SHH gradient such as
Pax6 and Nkx2.2 (Ericson et al., 1997). SHH has an importantrole in the glial cell
differentiation beside the floor plate differentiation (Lu et al., 2000). As described
before, the role of SHH in induction of ventral motor interneuron precursor types
(VO-V3). However, someclasses of the ventral interneurons develop in SHH mutant,
which suggests a role of other molecules.
From the RoofPlate:
There are secreted proteins from the roof plate which havea similar role as the
floor plate as an organising centre for the dorsal neuronsof the spinal cord (LaBonne
and Bronner-Fraser, 1999).
Experiments were carried out to test the role of the roof plate in the
differentiation of the dorsal interneurons in mouse embryo, namely ablation of the
roof plate. The result of this experiment was loss of all interneuron classes in the
dorsal region of the spinal cord (Leeet al., 2000).
BMPs:
BMPs(bone morphogenicproteins) are a subfamily of the TGF-B superfamily
that is comprised of more than 30 proteins (Kingsley, 1994; Zhao, 2003). They have
a role in dorsoventral and or anterior posterior patterning during embryogenesis
(Mishina, 2003), in addition to their functions in the progression, differentiation and
developmentofparticular regions in the brain.
BMP2 has a role in migration of neural crest cells in developing embryo
(Correia et al., 2007). It is expressed in the roof plate and hasa role in the closure of
the neural tube and is prominently in the surface ectoderm which implies role in the
cephalic region (Furuta et al., 1997). There is a relation between BMP2andtheglial
or CNSfates andretinal patterning, astrogliogenesis and neurogenesis (Fukudaetal.,
2007). In BMP2 null mouse embryos, the severity of defects in the development of
the neural tube depend on the amountof signalling of BMP2, suggesting a role of
BMP2in developmentof neural tube particularly the cephalic region (Castranio and
Mishina, 2009).
BMP4is also expressed in the roof plate and involved in the induction of
neurons with FGFs (Linker and Stern, 2004). Both BMP4 and BMP7interact with
Tsg protein biochemically and genetically (Zakin and De Robertis, 2004). There is a
co-expression of BMP7 and Tsg in ventral mesoderm and endoderm during
embryogenesis (Zakin et al., 2005). In BMP7 compound mutants, Tsg is necessary
for the formation of the posterior ventral structures (Zakin et al., 2005).
GDF7is another protein that belongs to this family, and is expressed by cells
in the roof plate of the mouse embryo. The differentiation of D1A and D1B subtypes
of dorsal sensory interneurons requires GDF7 as demonstrated by creating GDF7
null mutants mouse embryo. The analysis of these mutants revealed loss of DIA
dorsal sensory interneuron’s production. This evidence suggested expression of
GDEF7is essential for the neuronal cell types in the dorsal spinal cord (Leeetal.,
1998).
There is a possibility that BMP 7 and GDF7act as a heterodimer complex on
the cells of roof plate to function as chemorepellent. This evidence suggested the
heterodimer complex is essential for commissural axon trajectory (Butler and Dodd,
2003), also their repellent action on precommissural axon, which prevent it from
passingto the dorsal region (Butler and Dodd, 2003; Leeet al., 1998).
In addition, experiments in Zebrafish revealed that BMPs are necessary for
development of the sensory neurons and interneurons (Nguyenet al., 2000). BMP,
dorslin and activin are members of the TGF-B family, which control the fate of
dorsal regionof the neural tube (Liem et al., 2000; Liem et al., 1997).
Noggin, chordin andfollistatin are BMP antagonists that are expressed in the
notochord, whereas BMPs are secreted from the roof plate (Chizhikov and Millen,
2005; Lupoetal., 2006; Wilson and Maden, 2005). There is a role for BMPs and
their antagonists in specification of both ventral and dorsal cell types. The integration
between BMP and SHHsignalling, promotes the response of neural cells to SHH.
Incubation with BMP and SHHresults in reduction of the ventral cell fate of spinal
cord when compared with SHH only. However, incubation of SHH with a BMP
antagonist such asfollistatin on spinal cord explants results in increase in the ventral
cell fate (Liem et al., 2000; Lupoet al., 2006). The loss of roof plate cells leads to
abortive midline induction and holoprosencephaly which is the most common
congenital malformation ofthe brain particularly, in the dorsal telencephalon (Cheng
et al., 2006).
Axon guidance:
The nervous system is formed by network of neuronsthat innervates the whole
body. Each Neuronconsists ofa cell body, with an extended long axon from oneside
and multiple dendrites from the other side. A synapse is a point of meeting between
two neurons whichis responsible for signal transmission, most commonly between
an axon and dendrites. Axonstravel for long distances to reach their targets; certain
factors control this process. In particular, specific molecules act as cues to guide
these axons by attracting or repulsing mechanisms toward the final destination.
These molecules are called axon guidance cues and could be attractive or repulsive.
Someof these cues work as both depending on which receptor subtype are expressed
on the surface of growth cone. Axon guidance molecules can be contact-mediated or
sereted gradient.
The growth coneis the highly sensitive region of the axon which explores the
surrounding environment searching for guidance cues that allow the axon to either
elongate or shorten depending on the type of these cues. In response to this process
the growth cone sends projection like endings called lamellipodia and filopodia
(figure1.2). Actin filaments form the cytoskeleton of lamellipodia, where the filopdia
have F actin bundles, which are responsible for growth cone movement. The
microtubules move to the proximal part of the growth cone when associated with
actin filaments. This, according to the polymerisation or depolymerisation of the
actin filamentsis at the negative and positive ends (Huberet al., 2003).
Netrin:
Netrin-1 is the earliest secreted protein that was identified in chick brain thatis
considered an attractant guidance molecule in the nervous system of vertebrate
animals (Serafini et al., 1994). In particular, commissural axons are attracted to the
midline while trochlear axons are repelled (Serafini et al., 1996). Netrin may act as
attractant or repellent according to the receptor expressed on the surface of the
growth cone (Chisholm and Tessier-Lavigne, 1999; Mehlen, 2003).
Netrin-1 mRNAwasexpressed in the floor plate while Netrin-2 in the ventral
two thirds of the spinal cord. Interestingly, both molecules act together to attract the
commissural axons (Kennedyet al., 1994). Deleted in colorectal cancer (DCC) is an
Ig superfamily transmembrane protein which has a role in commissural axons
guidance by Netrin-1. Netrin-1 becomesan attractant when bound to DCC. However,
formation of a complex of DCC and UNC-5 heterodimer receptor on the surface of
the growth conealters the Netrin-1 action. It becomes repulsive such that trochlear
axons are repulsed from the midline (Huberet al., 2003). The level of cAMP is
essential with DCCsignalling, any decrease in the level of cAMPled to repulsion
while any increase resulted in attraction (Huberetal., 2003).
The commissural axons were unable to recognise the floor plate in absence of
DCC, while most axons are misdirected in both Netrin and DCC mutants. However,
some axonsare still attracted to the floor plate. This suggested the action of other
cues that are able to attract the commissural axon to the floor plate in addition to
Netrin (Fazeli et al., 1997; Serafini et al., 1996). There is evidence that SHH has a
role in attraction of commissural axonto the floor plate when it binds to Smoothened
(Smo), Smo or SHH receptor (Charron et al., 2003). In addition, SHH and Netrin
togetherattract axonsto the midline of the spinal cord (Salinas, 2003).
Loss of the growth cone response to guidance cues could be due to down
regulation of surface receptors when stimulated by these cues, as occurred in the
embryonic cortical neurons when stimulated by Netrin-1 that ended in a remarkable
decrease of DCC expression onthe cell surface. This evidence suggested that Netrin-
1 encouragesthe proteolytic cleavage of DCC (Kim etal., 2005).
Slit:
Slit is a protein secreted by the notochord that contributes to the successful
crossing of the midline by commissural axons. Expression of Slit was detected early
in the notochord, then the floor plate and finally in roof plate and motor neurons.
Some axons are attracted to the midline and once they cross the midline, they
navigate away, while other axons are repelled from the midline. A harmony is
required between these molecules and the receptors expressed on the surface of the
axons guide them to their targets. For example, Netrin, which is produced by the
ventral floor plate, guide the commissural axons to the midline (Kennedyetal.,
1994). Robo (roundabout) receptor expressed on the surface of the commissural
axons, which interacts with Slit that is secreted by the floor plate. This interaction
results in repulsion of these axon from the floor plate (Broseet al., 1999: Hu, 1999;
Krameret al., 2001) Robol and DCCinteracted to decrease the reaction of the axons
to the Netrin allowing them to cross the midline (Dickson and Gilestro, 2006; Stein
and Tessier-Lavigne, 2001). To avoid crossing back to midline, Robo receptoris re-
expressedafter leaving the midline (Kelemanet al., 2002; Kelemanet al., 2005).
Slit is expressed in different isoforms; slitl and slit2, whichare secreted by the
floor plate and interact with Robo-2 expressed on inferior olivary nucleuscells. In
forebrain, Robo-1 as well as Robo2 are expressed especially in the nuclei and axon
tracts. Robo-1 is crucial for embryonic vertebrate forebrain axon guidance and neural
differentiation. Abnormal expression of Robo-1-resulted in disruption of forebrain
axon development and ectopic differentiation of the neurons (Connor and Key,
2002).
Semaphorins:
Semaphorins are a large family of axon guidance molecules which have an
important role in guiding axons in the nervous system in both invertebrates and
vertebrates (Tamagnone and Comoglio, 2004; Yazdani and Terman, 2006). The role
of Semaphorins is guiding axons through repulsion or attraction. For example,
cortical axons guided bythe repellent action of semaphorin D andattraction effect of
semaphorin E. Interestingly, semaphorin 1 which is mainly repellent, becomes an
attractant molecule when overexpressed in developing peripheral neuron (Wong et
al.; 1999).
There are secreted or membrane bound isoforms of semaphorins. They interact
to form homodimers to initiate signalling pathway. Complexes of plexins and
neuropilins are surface receptors that are expressed on axons are required for the
signalling of semaphorins (Raper, 2000; Tamagnone and Comoglio, 2000).
Motor axon growth and guidance are interrupted due to absence of Sema3A-
NP-1 signalling, which results in dorso-ventral guidance defect in both medial and
lateral motor axons. The medial subset of lateral motor column (LMC)neuronsare
guided to the ventral limb by sema3F-NP-2 (Huber et al., 2005). There is a link
between altered function of semaphorin molecules and certain degenerative diseases
such as epilepsy, schizophrenia, Alzheimer, Parkinson’s disease and retinal
degeneration (Eastwoodet al., 2003;Rice et al., 2004; Yazdani and Terman, 2006).
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Ephrins:
Ephrins are membrane bound axon guidance molecules which function in
contact with their receptors on the opposing cell, Ephrin (Eph) tyrosine kinases are
surface receptors for Ephrins. Eph A receptors interact with class A Ephrins which
have a GPI anchor, while Eph B binds to class B Ephrins that have a cytoplasmic
domain.Initially, cis interactions between Ephrins and their Eph receptors on thecell
surface result in dimer formation, followed by trans interaction between these dimers
and dimers on the adjacent cell to form tetrameric complexes which initiate
signalling pathway in both directions (Kullander and Klein, 2002; Murai et al.,
2003).
During gastrulation, Ephrins and Eph B have an essential role in cell
movement, furthermore, B-Ephrins were detected in Zebrafish particularly in the
notochord and prechordal plate (Chan et al., 2001). In addition, they have a role
during hindbrain rhombomere development, migration of neural crest and
synaptogenesis (Klein, 2001).
During developmentof the retinal tectal system, Ephrins and Eph receptors
are essential for the guidance of retinal ganglion cells axons, to form the
retincollicular map (Erskine and Herrera, 2007; Huot, 2004; Knoll and Drescher,
2002).
In ephrin-A5 knockout mice, the commissural axons were temporarily changed
at PS in the hippocampus. In the dentate gyrus, they lost the direction during the
development and the numberof synapses and the commissural layers were changed.
This evidence suggests that Ephrin-AS plays a role in hippocampus synapse
maturation, whereas mRNA ofephrin-A3 expressed in the cells of the hippocampal
and the dentate gyrus during postnatal development(Otalet al., 2006).
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Wht:
Wntplaysa role in attraction and turning of commissural axonsafter crossing
the midline. It is a secreted axon guidance molecule that interacts with surface
receptor on the commissural axonscalled Frizzled3 (Zou, 2004). Wntis essential for
anterior projection, so, lack of Frizzled receptor in mutant embryosleadsto a defect
in anterior projection of commissural axons after crossing the midline. The attraction
role of Wnt could be reversed by the effect of secreted frizzled-related protein which
is considered as a Wnt antagonist (Lyuksyutovaet al., 2003).
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Lipid rafts and their role as location for GPI-anchored proteins:
Lipid rafts are unique microdomains in the cell membrane which are
characterised by their high constitution of cholesterol and sphingolipids that provide
a tight ordered state (Figure 1.6)(Brown and London, 2000). The size of these
microdomains is open to debate, some people say it is less than S5nm which was
determined by fluorescent energy transfer (FRET) assays (Anderson and Jacobson,
2002; Sharma et al., 2004), while others suggest is 200nm (Simons and Ikonen,
1997; Simons and Toomre, 2000). GPI- anchored proteins and cell adhesion
molecules locate to lipid rafts giving these putative microdomains an importance in
signal transduction for extracellular cues (figurel.5) (Nakai and Kamiguchi, 2002).
Most cell surface GPI anchored proteins are using lipid rafts as platforms for their
signalling pathways, in addition, many signalling pathways such as Rho and GTPase
and Src-family of tyrosine kinases are associated with these microdomains to
regulate the actin cytoskeleton, cell adhesion and motility (Guirland and Zheng,
2007). The clustering of individual rafts collectively by cross-linking and antibody
patching suggested they may facilitate signal transduction (Friedrichson and
Kurzchalia, 1998).
These microdomainsplay an essential role during the development of neuronal
axons. For example, Netrin-1 axon guidance molecule leads to extension of
commissural neurons outgrowth when they form a complex with DCC receptor that
is located within the lipid rafts (Herincs et al., 2005). In addition, lipid rafts play a
role in the development of normal brain and recovery after injury and diseases by
acting as a platform for various signaling pathways (Guirland and Zheng, 2007).
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Cell adhesion molecules Ig Superfamily:
Ig Superfamily is characterised by the presence of Ig domains and fibronectin
III repeats, they are subdivided into subfamilies according to the number of Ig
domains and FNIII repeats. Their GPI anchor locates them in lipid rafts of cell
membrane or they may be transmembrane, with some cytoplasmic domains having
tyrosine kinase or phosphataseactivity.
N-CAMs:
N-CAMsare cell adhesion molecules that are expressed on the surface of
neuronal cells, and have a role in development of the nervous system by promoting
neurite outgrowth and axon guidance (Brummendorf and Rathjen, 1995; Margetal.,
1999: Stoeckli and Landmesser, 1998). They have homophilic or heterophilic
interactions between the molecules within the Ig superfamily either in cis or trans on
the plane of membrane.
They are composed of five Ig domains and two FNIII extracellular repeat
domains. They are classified into different isoforms according to the molecular
weight, N-CAM 180, N-CAM 140, N-CAM 120, in addition to a secreted form
(Hubschmannetal., 2005; Kaluset al., 2006). They are expressed by differentcells,
for instance, N-CAMs120 are GPI-anchored molecules expressed by both neural and
glial cells, N-CAMs 140 and N-CAMs180are class | transmembraneproteins with
cytoplasmic domains. They have an essential role in synaptogenesis and synaptic
plasticity in adulthood (Doherty etal., 1995). The N-CAM subfamily is modified due
to the insertion of optional alternative spliced exon (VASE) in the fourth Ig domain
beside the posttranslational addition of poly-sialic acid (PSA)to the fifth Ig domain.
The increase in expression of PSA in the embryo is only in sites with a high
plasticity in adult, and expression of VASE exon during development led to a
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hypothesis that any increase in VASE with a decrease in PSA expression changed N-
CAM from a plasticity-promoting molecule to a stability-promoting molecule
(Bonfanti, 2006; Gascon et al., 2007; Rutishauser, 2008). Furthermore, N-CAMs
interact with the fibroblast growth factor receptor (FGFR). There is a more compact
interaction between Ig domains 1&3 due to decrease expression of PSA while PSA-
N-CAMsareless tightly packed (Ronnetal., 2000).
The FGFRhasa crucial role in N-CAM mediated axonal elongation (Kiselyov
et al., 2003; Neiiendam etal., 2004; Saffell et al., 1997). The hypothesis is that N-
CAMsform dimers on the surface of the cell, a trans homophilic interaction of N-
CAMsactivate these dimers, which resulted in clusters formation by FGFR and N-
CAM molecules that increase the local concentration of FGFR (Kiselyov etal.,
2005). However, the real mechanism of N-CAM activation of FGFR is not fully
understood.
Both N-CAM 140 and N-CAM 180 depend on the intracellular and
extracellular interaction partners to trigger the downstream signal complexes. These
isoforms are located either within or outside lipid rafts of the cell membrane. N-
CAM 140 withinthelipid raft is able to signal alone possibly through the FYN/FAK
complex. Whereas, N-CAM 140 outside the lipid rafts signals mainly through the
FGEFR (Niethammeret al., 2002). N-CAM 120 is GPI anchored, while N-CAM 140
and N-CAM 180aretargeted bythelipid rafts due to palmitoylation of four residues
in the intracellular juxtamembraneregion (Neiiendametal., 2004).
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L1:
L1 is essential for axon elongation in addition to its role in pyramidal tract
formation, cerebral cortical motor neurons connection and interneuronsto the spinal
cord. L1 is another neural transmembrane glycoprotein subfamily belonging to the Ig
superfamily. It consists of six Ig domains and five FNIII repeats (Brummendorf and
Rathjen, 1996). L1 interacts in trans either homophilically or heterophilically with
other cell adhesion molecules such as Axonin/TAG-1, F3/F11/Contactin
(Brummendorf and Lemmon,2001).
There is a link between L1 and Sema3A signalling pathway during
corticospinal tract axon guidance. This was suggested becausethe repulsive signal of
Sema3A in the ventral spinal cord waslost in L1 deficient mice. The extra cellular
domainsof the L1 interact in cis with NP-1 forming the NP-plexin-Sema3A receptor
complex (Castellaniet al., 2000).
There are cell adhesion molecules with three Ig domains that belong to Ig
superfamily; that are thought to play a role in development of the nervous system
namely Synaptic cell adhesion molecules (SynCAMs), nectin, neuroplastins and
IgLONs.
SynCAMs:
SynCAMsplaya role in neuronal differentiation of the central and peripheral
nervous system during developmentand in the adult brain. There are four proteins 1-
4, with their corresponding CADM1-4 genes (Biederer, 2006). They are formed of
three extracellular Ig domains with a transmembrane domain and cytoplasmic
domain (Biederer, 2006). All SynCAMsare expressed in the nervous system whereas
synCAMI1is mainly expressed in the brain with expression pattern outside the
nervous system in lung and testis (Fogel et al., 2007). These molecules are expressed
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in synapses of the developing hippocampal neurons in vitro (Fogel et al., 2007),
especially SynCAM1-3 which are expressed at both pre and post synaptic membrane
(Biedereret al., 2002). SynCAM4is expressed by cerebellar Purkinje cells, whereas
synCAM3 is expressed by cerebellar granule cells. This suggests to a role for
synCAM3-4 interaction between these cells during cerebellar differentiation
including synaptogenesis (Thomasetal., 2008).
SynCAMshave homophilic and heterophilic interactions inside the family, the
heterophilic interaction between synCAMs1 and 2 promotes synaptic transmission
(Biederer et al., 2002; Fogel et al., 2007; Sara et al., 2005). SynCAMs 3 and 4
interact (Biederer et al., 2002; Fogel et al., 2007; Kakunagaet al., 2005; Maurel et
al., 2007; Shingai et al., 2003) as do synCAMs 2 and 4 (Thomas etal., 2008).
SynCAMs1, 2 and 3 also have homophilic interactions.
Nectins:
Nectins are a family of cell adhesion molecules that is similar to the SynCAM
family in the structure (3Ig) and the number of members within the family (1-4) with
variantsplicing forms (Cocchi etal., 1998; Lopez et al., 2001; Reymondet al., 2001;
Satoh-Horikawa et al., 2000; Takahashi et al., 1999). They have extracellular or
intracellular interactions which lead them to have essential roles in cell adhesion,
proliferation, polarisation, in addition to their role in formation of intracellular
junctions. Nectins 1, 2 and 3 are expressed in embryo andadult tissues while nectin4
is expressed mainly in human placenta (Reymondetal., 2001).
There are cis and trans homophilic and heterophilic interactions between
Nectins as well as other molecules. Initially, Nectins form cis dimers on the surface
of the cell through the second Ig domain then these dimers interact in trans with
Nectins or other molecules on the adjacent cells through the first Ig domains. In
17
trans, nectinl interacts with nectins3 and 4, while nectin2 interacts only with nectin3.
In addition, nectin-3 interacts with nectin-like molecule-5 (Necl-5) that helps in the
organisation of cell movement and proliferation. On the other hand, cis interactions
occur between nectins1-3 with integrin a-B which results in signal transduction to the
cytoplasm to rearrangethe actin cytoskeleton (Ogita and Takai, 2006), while nectin-3
interacts in cis with platelet derived growth factor receptor (PDGFR)that promotes
the signalling of cell survival (Rikitake and Takai, 2008).
The ectopic overexpression of nectin-1 in dendrites of cultured rat hippocampal
neurons, (which normally express nectin-3 on dendrites and nectin-1 on axons) led to
abnormal dendro-dendritic and excessive axodendritic interactions. This suggests the
essential role of expression of nectin-1 is on axons and nectin-3 is on dendrites
(Martinez-Ricoet al., 2005; Togashiet al., 2006).
Neuroplastins:
Neuroplastins are cell adhesion molecules of Ig superfamily that are thought
to have a role in the developmentandplasticity of synapses in humanandvertebrates
(Bernstein et al., 2007; Smalla et al., 2000). There are two isoforms of neuroplastin
(np); np -65 which is comprised of three Ig domain whereas np-55 that has two Ig
domains (2-3) (Owczareket al., 2009). They were called previously, gp65 and gp55.
Np-65 is expressed mainly in brain while np-55 is more widely broadly expressed
(95% of neuroplastins) (Smalla et al., 2000). Both isoforms are expressed in cell
bodies and neurites of forebrain, cerebellar neurons, developing and adult retina and
optic nerve (presynaptic). Interestingly, there are variations in expression patterns of
neuroplastins between different species in vivo and in vitro, where np-55 is
expressed mainly in rat and mouse cerebellum while np-65 is common in human
cerebellum and hippocampus (Bernstein et al., 2007; Buckby et al., 2004).
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Immunocytochemistry studies, revealed that both isoforms are expressed in both
innerpexiform (IPL) and outerplexiform (OPL) layers of retina (presynaptic), while
in situ hybridization studies suggest pre &post synaptic expression of np-65 in the
outer plexiform layer which increased postnatally (OPL) (Kreutzet al., 2001).
Np-65 has a role in initiation of the long-term potentiation (LTP) of
hippocampal neurons, through mitogen-activated protein kinas p38 (p38MAPK)
activation. The mechanism of np-65 in p38MAPK modifies the expression of surface
glutamate receptor (Empsonet al., 2006). The mechanism of np-55 was notclear.
Furthermore, np-55 induced signalling is suggested to have a role in synaptic
plasticity (Owczarek et al., 2009), there is evidence that suggests a genetic relation
between neuroplastin and schizophrenia (Saitoet al., 2007).
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IgLONs Family:
IgLONsare cell adhesion molecules that are members of the Ig superfamily.
They are thoughtto have a role for the developmentof the nervous system byacting
as axon guidance molecules. IgLONs are comprised of four members, opiate-binding
cell adhesion molecule (OBCAM)(Schofield et al., 1989), limbic system-associated
membrane protein ( LAMP) (Brummendorf et al., 1997; Hancox et al., 1997;
Pimentaet al., 1995; Wilson et al., 1996), Neurotrimin (Ntm) (Struyk et al., 1995)
and the last discovered memberis Kilon (kindred-IgLON) (Funatsu et al., 1999).
GP55 glycoprotein has a mixture of all members of the group in chick (Wilsonetal.,
1996). Cerebellum-Purkinji-1 (CEPU-1) is a chick homologue for Neurotrimin
(Brummendorf and Rathjen, 1996) whereas Neurotractin (Marg et al., 1999) is the
homologue for Kilon in chick (figure1.3).
Structure of IgLONs:
IgLONsare highly glycosylated GPI-anchored proteins which are formed of
three Ig domains, and are located in lipid rafts on the cell surface. IgLONs have six
or seven N-glycosylation sites which comprised more than 20% of their molecular
mass. In rat brain, IgLONs were analysed for glycosylation sites, the peptide and
carbohydrate section. The glycosylation is important for cell-cell interactions
(Kleene and Schachner, 2004). The first Ig domain is highly glycosylated with high
mannose oligosaccharides in all IgLON proteins. The high heterogenousity of the
third Ig domainsdue to the linkage of diverse oligosaccharides which include BA-2,
a brain specific glycan, is more abundant in mammalian brains than other tissues
(Chenet al., 1998; Itoh et al., 2008; Nakakitaet al., 1998)(figure1.4).
IgLONshave different isoforms in chick; there are al and a2 isoforms for
OBCAM, CEPU-1 (Ntm) and LAMP which differ in long signal peptide of N-
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terminal, there is also a B isoform for CEPU-1 and LAMPwith additional 11 or 12
amino acids (Brummendorfand Rathjen, 1996; Lodgeet al., 2000). In addition, there
are two isoform for Neurotractin (Kilon), Ntr-L is the long isoform and Ntr-S is the
short which has only two Ig domains (Funatsu et al., 1999; Marg et al., 1999).
Exceptionally, CEPU-1 exists in a secreted isoform CEPU-1-Se, where no GPI
anchoris attached to the molecule (Lodgeet al., 2000).OBCAMalso has a putative
secreted isoform which was isolated by our research group (unpublished data).
IgLONsshow a high sequence homology between their members (Brummendorf and
Rathjen, 1996).
IgLONsactivity:
GP55is chick glycoprotein which has a mixture of IgLONs molecules; CEPU-
1, OBCAM, LAMPand Neurotractin (Wilsonet al., 1996). Forebrain and dorsal root
ganglion (DRG) neurons were unableto initiate their neurite when cultured on GP55.
This is supported by another experiment in which the forebrain and DRG neuronal
cell bodies were unable to send their neurites across an island of GP55 (Clarke and
Moss, 1994, 1997). However, the inhibition that was caused by GP55 was reversed
by using pertusis toxin (PTX) (Clarke and Moss, 1997). This evidence suggested the
role of IgLONs as negative guidance molecules during development was possibly
through a trimeric G protein complex.
Neurite outgrowth assays were used to investigate the activity of single
IgLONs on the ability of the neurons in extension of their neurites. Surprisingly,
DRGneurons were able to extend their neurites on single IgLON-transfected CHO
cells and when single IgLON-Fc recombinant proteins were used as substrate,
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furthermore, no inhibition occurred with a mixture of IgLON-Fe recombinant
proteins (McNameeetal., 2002).
The neurite outgrowth from DRG and hippocampal neurons was encouraged
by Ntm-Fe recombinant protein, whereas neurite extension by sympathetic neurons
was inhibited (Gil et al., 1998). This suggested a dual effect of neurotrimin on the
neuronal outgrowth. DRG neuronsthat express Ntm and LAMP or OBCAMat low
level were cultured on LAMP-CHOcells as substrate resulted in reduction of the
length of neurite outgrowth. This evidence suggested the inhibition of neurite
extension due to a heterophilic trans interaction between Ntm and LAMP (Gil et al.,
2002).
CEPU-Se is a secreted isoform of CEPU-1, mRNA of both CEPU-Se and
CEPU-1 are co-expressed in retina and developing and adult cerebellum. CEPU-Se
needs to be in dimeric form to interact in trans with CEPU-1, OBCAM and LAMP-
CHOcell lines, whereas it showed no homophilic or heterophilic interaction with
IgLON-transfected cell lines when provided as a monomer. CEPU-Se/laminin
substrate allows dissociated DRG neurons to grow and extend their neuritis.
However, DRG explants were unable to extend their neurites to areas coated with
CEPU-Se,so, it may have a role in modulation of IgLONsinteractions (Lodge etal.,
2001).
Previously, cell adhesion assays revealed that CEPU-1-Fc bound to chick
sympathetic neurons that express LAMP, CEPU-1 and OBCAM (Lodgeetal., 2000;
McNameeet al., 2002). These assays carried out on cerebellar granule cells also
showed strong binding to CEPU-1-Fe and OBCAM-Fe while LAMP-Fe bound
weakly, even though reverse-transcription PCR and immunofluorescence staining
revealed that cerebellar granule cells express CEPU-1, OBCAM and LAMP(Reedet
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al., 2004). Investigation on the ability of binding the chimeric proteins to the surface
of the cerebellar granule cells, and relative affinity of protein-protein interaction
between IgLON molecules werecarried out to clarify the previous results. LAMP-Fc
did not bind to the cerebellar granule cells while both CEPU-Fc and OBCAM-Fc
binding was detected. There was no explaination of the fact that LAMP-Fc was
unable to bind since it should bind to CEPU-1 or OBCAM (Reedet al., 2004).
Although, LAMP-Fc bound to transient transfected OBCAM-CHOcell line, this
binding can be reduced or abolished by co-expression of LAMP. This suggests that
IgLONsact as heterodimeric proteins on the plane of the membrane (DigLONs).
Recent result show inhibition ofinitiation of neurite outgrowth from forebrain
neurons by CEPU-1-OBCAM or CEPU-1-LAMPtransfected CHOcelllines, while
single CEPU-1 or OBCAM transfected CHO cell lines failed to inhibit neurite
outgrowth (Christine McNamee PhD thesis, University of Liverpool 2008)
(figure1.5). CEPU-1-OBCAM transfected CHO cell lines also inhibit cerebellar
granule cell neurite outgrowth whereasno inhibition occurred with single transfected
CEPU-1 or OBCAM CHO cell lines. This evidence suggests that the pairs of
IgLONs on the CHO cell surface may form dimers and explains the inhibition of
neurite outgrowth caused by GP55 which may contain a combination of different
IgLON molecules in heterodimeric forms (DigLONs) (Reed et al., 2004) (figure1.6).
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Co-expression of IgLONs:
IgLONs are co-expressed in certain area of the nervous system during
particular stages of development. Neurotrimin (CEPU-1) and OBCAMare usually
co-expressed in the hippocampus (Struyk et al., 1995) whereas Kilon (Ntr) and
OBCAM co-expressed in the cerebral cortex and hippocampuswith an increase post
natally (Miyata et al., 2003a). In addition, co-expression of both neurotrimin and
LAMP using neurotrimin and LAMP antibodies revealed expression on a
subpopulation of CNS neurons from E16 dorsal root ganglion (DRG), E18 thalamus,
olfactory bulb and hippocampus. Double staining with specific antiserum showed co-
localisation of both LAMP and Neurotrimin (CEPU-1) on surface of the most
hippocampal neurons and 80-90% of olfactory neurons, whereas 10% express LAMP
only (Gil et al., 2002).
IgLONsinteractions:
IgLONs have homophilic and heterophilic interactions between the members
of the group, and different studies were used to inspect these interactions using
IgLON-Fe recombinant proteins and IgLON-transfected cell lines. CEPU-1,
OBCAMand LAMPtrans homophilic and heterophilic interactions were confirmed
by the immuno-affinity studies of IgLON-Fe recombinant proteins and IgLON-
transfected cell lines (figure1.7) (Brummendorfetal., 1997; Lodgeetal., 2000; Reed
et al., 2004). Some IgLONsare not knownto haveinteractions with other molecules
from outside the group. This was suggested when OBCAM-Fc and Ntm-Fe (CEPU-
1) recombinant proteins bound to LAMP-transfected CHO cells, whereas other Ig
superfamily molecules such as L1, contactin or NCAM recombinantproteins failed
to bind to LAMP-CHOcells (Gil et al., 2002). The situation is different for Kilon
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(Ntr) due to its two isoforms; Ntr (L) and Ntr(S), Ntr-Fe recombinant protein was
used in binding studies with IgLON-transfected cell lines. The intensity of
interaction varies according the cell line and the isoform of Kilon, on CEPU-1-
transfected CHOcell line, both Ntr (L) and Ntr (S) interact strongly, whereas with
LAMP-transfected CHO, Ntr (L) has weak interaction and Ntr(S) has much weaker
interaction (Marg et al., 1999). Kilon interacts heterophilically with OBCAM in
trans (Miyata et al., 2003b).
Expression of IgLONs:
IgLONs are expressed within the nervous system and specific regions in the
body. They have roles during all stages of development and in the adult. They are
thought to have role in early development including migration and differentiation
of the neuronal precursors in the central nervous system. Afterwards, with
development the expression of IgLONs increases which suggested anotherrole in
axon outgrowth alteration. In addition, they might be regulating synapse formation.
In adult, the level of expression becomes higher than in development which implies a
role in synapseplasticity and nervous regeneration.
During migration and differentiation:
CEPU-1 and LAMPare suggested to be implicated in differentiation and
migration of certain brain regions during early stages of development. In the neural
tube, LAMP mRNAwasexpressed by the anterior region of the neural tube beside
the migrating neural crest cells and the notochord. Their presence at this time
suggested that IgLONs might be implicated in the neuro-epithelium and neural crest
cells interaction (Kimuraet al., 2001). CEPU-1 expression wasfaint in the anterior
ectoderm, migrating mesenchymeandincreases in intensity in the neural plate. Later
on, mRNA of CEPU-1 is situated in the forebrain, midbrain and anterior region of
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the hindbrain as broad band. As the embryo develops around the second embryonic
day, it becomes morelocalised as distinct band to the midbrain-hindbrain boundary
or at isthmus. At this stage, CEPU-1 and particular molecules such as Wntl, EphB3
and FGF8 were colocalised, suggesting IgLONs may act alongside these molecules
(Jungbluthet al., 2001; Kimuraet al., 2001). By E3, CEPU-1, OBCAM and LAMP
are expressed in the notochord, whereas the floor plate expresses CEPU-1 and
OBCAM.This evidence suggested the role of IgLONsin induction of differentiation
of the neural plate midline cells into floor plate. No expression of Neurotractin in this
stage was detected (Sahar Youssef PhD thesis University of Liverpool 2007).
During axons outgrowth:
During development of the embryo, in rat brain, Neurotrimin (CEPU-1) has
limited expression to postmitotic neurons, and then increased in forebrain at the age
of 15 embryonic days, so it is considered the highest in primary sensory and motor
regions of the brain (Gil et al., 2002; Struyk et al., 1995). Initially, LAMP is
expressed by limbic system neurons,cortical and subcortical neurons, medial nucleus
of the thalamus and eventually in regions of the brain that are related to learning,
memory, cognitive behaviour and autonomic function (Horton and Levitt, 1988;
Levitt, 1984; Pimenta et al., 1996; Reinosoet al., 1996). LAMP was suggested to be
responsible for selective axon guidance to certain regionsin the cerebral cortex due
to its limited expression in non limbic thalamo-cortical regions; limbic thalamic
axons that express LAMP were attracted to LAMP, while the non limbic thalamic
axons were repelled (Mannet al., 1998). In LAMP knockout mice, there were no
differences in axonal projection (Catania et al., 2008). Mainly, OBCAM is expressed
in the cerebral cortical plate and hippocampus regions of the brain (Miyataet al.,
2003b; Struyket al., 1995). Kilon (Ntr) the last discovered memberof the group; it is
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expressed by embryonic age (E16) in rat brain and then showsgradual increase with
development. In early postnatal rat, cortex and hippocampus are the sites for
expression of kilon, while in adult, expression decreases in the cortex and remains
high in dentate gyrus of hippocampusand cerebellum (Braueret al., 2000; Funatsu et
al., 1999). In chick, Neurotractin was expressed by a subset of commissural and
longitudinal axon tracts in central nervous system with an increase during
developmentwhich continuesin the adult (Marg et al., 1999). LAMP mayplaya role
in developmentof the visual system outside the nervous system,as it is expressed in
the optic fibre layer of chick retina and the tectum at E7 age (Brummendorfetal.,
1997). IgLONs are expressed in different layers of retina as revealed in previous
immuno-localisation studies on E18 chick retina frozen sections. LAMP and CEPU-1
co-expressed in the outer plexiform layer which is the site for synapse between
bipolar cells and photoreceptors. The inner plexiform layer is the region for retinal
ganglion cells and bipolar cells to form the synapse, where LAMP and OBCAM
colocalised. While Neurotractin expressed in the outer plexiform layer of the retina
(Lodgeetal., 2000).
During synaptogenesis:
The expression of IgLONsmight be related to synapse formation particularly
on dendrites. Firstly, expression patterns of Neurotrimin (CEPU-1) implya role
in formation of excitatory synapsesin the cerebellum during development and
maintenanceto the adult stage (Chenetal., 2001). Initially, LAMP is expressed
on both axons and dendrites in limbic brain tissue, and then postnatally remains
at postsynaptic sites on dendrites (Horton and Levitt, 1988; Zaccoet al., 1990).
Specific antibody and antisense oligonucleotides were used to inhibit the
expression of OBCAM ondendrites of hippocampal neurons. This resulted in a
remarkable reduction in the numberof synapses, while when OBCAMwasover-
expressed; an increase in synapse formation is observed. This evidence suggests
OBCAM hasa role in synaptogenesis (Miyata etal., 2003a; Yamadaetal.,
2007). Dendrites of the cerebral cortex and hippocampusandcell bodies of
pyramidal neurons expresskilon (Ntr) (Funatsuetal., 1999), kilon (Ntr) was
identified on dendrites with double staining with post-synaptic vesicles protein
synaptophysin (Schaferet al., 2005). In addition, kilon and OBCAMare co-
localised mainly pre-synaptic
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sites on dendrites and in synapses of developing and adult brains. This was
confirmed with confocal imaging studies using the vesicle-associated membrane
protein 2 (Miyataet al., 2003a).
During adulthood:
There is a link between synaptic plasticity and high level of expression of
IgLONsin the limbic system and cerebral cortex during learning and developmentof
new memories processes (Funatsu et al., 1999; Levitt, 1984; Pimenta et al., 1996;
Struyk et al., 1995). Higher levels of LSAMP expression in rats correlates with
anxiety and the rats becomeless liable to explore an elevated plus—maze (Nelovkov
et al., 2003). LSAMP deficient mice become less alert and increase in their
exploration activities of a novel maze (Catania etal., 2008).
A comparative study for IgLONs expression in epithelial ovarian tumours to
normal ovarian tissue showed loss of gene expression of OPCML (OBCAM),
LSAMP(LAMP) and NEGR1(Kilon) whereas HNT (Ntm) wasincreased (Ntougkos
et al., 2005). While the loss of OPCML geneexpression is related with epithelial
ovarian cancer (Sellar et al., 2003) as well as with gliomas (Reedet al., 2007). This
suggests a role for IgLONs in the suppression of tumours. In tumours, the patients
have a bad prognosis due to low expression of LSAMPgene (Ntougkosetal., 2005).
There is a relation between LSAMPtranslocation with familial clear renal cell
carcinoma(Chenetal., 2007).
In this thesis, the aim is to generate CEPU: OBCAM-Fce (CO-Fc)
heterodimeric recombinant chimeric protein anduse it as tool to further characterise
the previous results of the CO double transfected CHO cell line which inhibit the
initiation of the neurite outgrowth of E8 forebrain neuron.
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Thefirst step is the generation of myc epitope tagged OBCAM-Fc bycloning
this construct into pBudCE4.1 plasmid, followed by single or double transient
transfections in order to test pBudCE4.1-OBCAM-Fc-myc and/or pcDNA6-CEPU-
Fc-V5 constructs. The next step is generation of stable CHO cell line and using
ELISA assay, dot blot and Western blotting for characterisation of CO-Fc
heterodimeric recombinantprotein (figure 1.12).
Finally, the activity of CO-Fe recombinant protein will be tested on neurite
outgrowth assay and compare it with the previous results of CO-CHO double
transfected cell line. In addition, immunofluorescence studies will be carried out to
investigate its interaction with the putative receptors on the cell surface of the
neurons, chick retina frozen sections and IgLON-transfected cell lines to identify the
role of IgLONsin formation of the putative receptors complex (figure1.13).
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Figure 1.1: The structure of the neural tube
Anillustration describes the formation of the neural tube from folding of the neural
plate to form the neural groove which then ends with formation of the neural tube.
Neural tube is formed by important structures; which have roles in the development
of the nervous system such as roofplate andfloor plate and the neural canal in the
middle. Notochord lies below the neural tube while the neural crest aboveit.
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Figure 1.2: Axon growth conethatattracted to its target by the
action of positive and negative cues
A diagram describes the structure of a growth cone which is formed of lamellipodia
and filopodia surrounded by different guidance cues; positive and negative. The
growth coneis guided to its target by the action of both cues. The cytoskeleton of the
growth cone is rearranged in response to the signal of the surrounding guidance
cues. Adaptedfrom (Huberetal., 2003)
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Attractive Cues (positive) Repulsive Cues (negative)
Receptor molecule Receptor molecule
DCC Netrin DCC+UNC Netrin
Plexin+NP(L1) Sema3
Eph Ephrins
Frazzled Wnt Derailed Wnt
Robo Slit
Plexin B Sema4 Plexin A Semal   
Table1.3: List of attractive and repellent axon guidance molecules
and their receptors
A table listed the different axon guidance molecules and their receptors, whether
attractive or repulsive.
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Figure 1.4: Attractive and repellent axon guidance molecules and
their receptors
An illustration describes the interaction between the cell adhesion molecules with
their receptors on the adjacentcell. These molecules became attractive or repellent
according to the type of the receptor that expressed. Netrin and DCC(positive),
while netrin, DCC and UNCS (negative). Slit and Robo (negative), Ephrin and Eph
receptor (negative).Semaphorin and NP (L1) (negative) (Dickson, 2002).
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Figure 1.5: Structure of Lipid rafts microdomainsin thecell
membrane
A diagram describes the structure of lipid rafts which consist of sphingolipids and
cholesterol. Sphingolipids are arrangedtightly to be detergent insoluble low-density
regions. They act as platform for GPI anchored proteins. Adapted from (Munro,
2003).
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a GPI-anchoredprotein in the membrane   Lumenof the ERcell surface
b Structure of the GPl-anchored-protein precursor
 
Signal peptidase GPIprotein transamidase
Mature protein J
+ +
; 4 1 2=Hydrophobic region
Ez Spacer region  
Vv
c GPI core structure
Sugar modifications
 
Attachment of sugars or
phosphoethanolamine
TT:
2 He o- °
1O=P-O Lipid modifications
© Mannose 9 H * Acylation of inositol ring aH2C—C——CH2 * Fatty-acid exchange or modification6 6 (changes in saturation,
€) Glucosamine on ¢ c= oO hydroxylation, linkage)I I + Lipid-backbone exchange
(CHahe (CH2he (DAG = ceramide)
&) Inositol CH3 CH3  
Figure 1.6: Structure of GPI anchored protein that attachedto lipid
rafts
A) The GPI anchored protein that located on the extracellularleaflet of the plasma
membraneby their GPI anchor
B) These proteins are synthesised in the lumen of endoplasmic reticulum with its
hydrophobic amino terminal region signal sequence and carboxyl terminal region
that attached the protein to GPI anchor.
C) The anchor is joined to the C-terminal amino acid by an ethanolamine, which is
linked to an oligosaccharide that consists of three mannose, N-acetylgalactosamine,
and glucosamine. The oligosaccharide is in turn joinedto the inositol head group of
phosphatidyl inositol. The two fatty acid chains of the lipid are embedded in the
plasma membrane(Mayor and Riezman, 2004).
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Figure 1.7: IgLON molecules in Rat and Chick andtheir related
Genes
An illustration listing the different IgLON molecules in rat; and their chick
homologues plus the nameoftheir genes
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Ino:
@ : high-mannose type, @ : complex type, @: hybrid type. ©: glycosylated, $2. unknown
A: fucose, oO : galactose, oO: mannose, i. N-acetylglucosamine, ?e: neuraminic acid, ‘| glucosamine
Figure 1.8: Structure of IgLONscell adhesion molecules
A schematic diagram describes the structure of different IZLON molecules; LAMP,
OBCAM,Neurotrimin (CEPU-1) and Kilon. There are multiple glycosylation sites.
IgLONsformedby three Ig domains andattachedto thelipid rafts of cell membrane
by GPI-anchor(Itohetal., 2008).
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Figure 1.9: CEPU-1 and OBCAM double transfected CHO cell line
inhibit the neurite outgrowth from E8 forebrain neurons
CO-CHOcells inhibit the neurite outgrowth from E8 forebrain neurons, where the
outgrowth was about 40% (yellow bar), while WT (red bar), CEPU-I(green bar)
and OBCAM (Blue) CHOcell line failed to inhibit their outgrowth, The percentage
of the outgrowth was about74%, 68% and 77% respectively ( p_ value
<0.01)(Christine McNamee PhD Thesis University ofLiverpool 2008).
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Figure 1.10: Homophilic and heterophilic trans interactions between
IgLON molecules
A diagram describes the affinity of trans interactions between CEPU, OBCAM and
LAMPmolecules. The highestinteraction is between LAMP and CEPU-1I then LAMP
and OBCAMfollowed by the homophilic trans interaction of CEPU-1, the next is
CEPU-1 and OBCAM andfinally the lowest interactions are the homophilic
interactions ofOBCAM and LAMPbased on ELISAassays (Reedet al., 2004).
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Figure 1.11: the proposed DigLONsthat can be formed by IgLONs
A diagram describes the possibility of six DigLONs formation of four IgLON
molecules; CEPU-1, OBCAM, LAMPandfinally Neurotractin. There is evidence for
CEPU-1: OBCAM CEPU-1: LAMP and OBCAM:LAMPexisting as DigLONs (Reed
et al., 2004).
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Figure 1.12: proposed structure of CO-Fc IgLON Heterodimer
complex
A schematic diagram describes the structure of CEPU-1: OBCAM-Fc heterodimer
complex which is formed of V5 tagged CEPU-1 chain and myc tagged OBCAM
chain, both chains are attached at Disulfide Bridge of the humanFctails.
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Figure 1.13: Aim of the thesis
This illustration describes the aim of this thesis starting from the molecular section
of the project which is cloning of OBCAM-Fc into pBudCE4.1 to form pBudCE4.1-
OBCAM-Fc-myc construct, then testing of this construct by transfection of CHO
cells, followed by stable double transfection with pcDNA6-CEPU-Fc-V5 to produce
CO-Fc recombinant heterodimeric protein. The recombinant protein was then
analysed by ELISA assay for characterisation of this protein as well as dot blot and
Western blotting. Finally, the activity of this protein was tested on neurite outgrowth
assay andits interaction with the putative neuronalreceptors.
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Chapter Two
Materials and Methods
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Molecular Biology:
OBCAM-Fcsequence was cloned into pBudCE4.1 vector (Invitrogen) to add
myc-His6 tags to the 3 prime end of the OBCAM-Fc sequenceprior to stop codon.
Primers were designed to add HINDIII and xbal restriction sites in frame either end
of the OBCAM-FC sequenceto enable cloning into the pBudCE 4.1 vector. PCR was
used to amplify OBCAM-Fc construct which had previously been cloned into
pcDNA3plasmid using proof reading Taq (Invitrogen).
PCRreaction for OBCAM-Fc construct in peDNA3:
Forward Primer:_5’-CCACTGCTTACTGGCTTATC-3’
Reverse Primer:_5’-GTCGCACTCATTTACCTCTAGACAG-3’
0.1ug-0.001ug Plasmid DNA lul
10mM d NTP mix 1.5ul
10uM of both forward and reverse primers 1.5ul
50mM MgSO, (pfx Taq polymerase) or
50mM MgCL)(ordinary Taq polymerase) lul
10XTaq polymerase amplification buffer Sul
Taq polymeraseor proof reading Taq lul
PCR grade water total volume 50ul
A negative control was used with no DNA.
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Temperature Time Cycles Function
94 10 minutes I Taq activation
94 1 minute DNAdenaturating
56 1 minute 30 Primerannealing
68 or 72 2minutes Strand extension
68 or 72 10 minutes 1 Strand completion
Table: PCR reaction.
Agarosegel electrophoresis DNA analysis:
Products of PCR were mixed with 2ul of x5 Blue juice ™loading buffer
(Invitrogen) plus 1.5ul/sample SYBER™ green DNA dye (Sigma). They were then
loaded onto a 1% Agarose gel, in TAE buffer containing 40 mM Tris-acetate 1m M
EDTA (50x stock 242g Tris base 571ml glacial acetic acid, 100 ml 0.5M EDTA
pH8.0 perlitre). UV excitation of SYBER ™green was used to visualise the PCR
product at a wavelength of 586nm and emission of 605nm. A molecular weight
marker 1Kb wasusedto identify the size of the PCR product.
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TA Cloning of PCR product into PCRIT TOPO™vector:
TOPO TA™(Invitrogen) cloning kit was used to clone the PCR product into
pCRII TOPO™vector (Invitrogen). Three 1 of PCR product wasincubated with |
ul pCRII TOPO ™vector, lu] TOPO™salt buffer and | wl of sterile water at room
temperature for 5 minutes, finally placed on ice for 20 minutes. The TA cloning
product was used to transform DHSa-T1® competent bacteria. Because proof
reading Taq was used for PCR reaction, 0.7-lunit of ordinary Taq was addedto the
reaction to add the 3’ A-overhangs
Competent bacteria transformation:
DH5a-T1® Competent bacteria were thawed on ice and 2 ul of TA cloning
product was mixed gentlyinto the bacteria cells then incubated on ice for 15 minutes.
Immediately, the bacterial cells were given a heat shock in a water bath at 42°C for
30 seconds. Two hundredandfifty microlitres ul of room temperature SOC medium
was addedto the mixture and shaken at 250 rpm at 37°C for lhour. 10, 50 and 100 ul
of the transformed competent bacteria were cultured on pre-warmed Luria Broth
(LB) or low salt LB agar plates with Kanamycin (5Omg/ml) antibiotic for pcRII
vector or Zeocin (50mg/ml) for pBudCE4.1vector. These plates were incubated for
24 hours at 37°C to allow the transformed bacteria to grow in colonies.
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Miniplasmid prep:
Sigma Miniplasmid kit was used to isolate the plasmid DNA. The maximum
yield of DNA out of the kit was about 20ug. The transformed competent bacteria
were cultured overnight in Sml of LB broth (or low salt LB broth) with 50 mg/ml
Kanamycin antibiotic (or Zeocin). The cultured mixture was spun at 3000 rpm for 10
minutes, and then the pellet was resuspended in RNAase buffer of the kit. Under
alkaline condition, these bacteria were lysed and neutralised, followed by steps of
binding of DNA to column provided with the kit. The column was spun with the
washing buffer, finally the DNA waseluted in SO ul DEPC treated water and stored
at-20°C. 1ul of a Miniplasmid prep DNA product was loaded and run on 1% Agarose
gel, [KB marker(Invitrogen) to identify the size of the miniplasmid product.
Double digestion with restriction enzymes:
Hind III and XbalRestriction enzymes (Invitrogen) were used to digest the
OBCAM-Fcinsert out of the pCRII If TOPO intermediate vector and pBudCE4.1
final vector (Invitrogen). Sixteen microlitres ul of DNA were digested with 2ul of
reactive buffer and lul of each restriction enzyme, followed by incubation of the
mixture for 1 hour at 37°C. The products were loaded onto a 1% Agarose gel, and a
1KB marker was used to measure the size of the OBCAM-Fcinsert and the opened
pBudCE4.1 vector. Both digested OBCAM-Fc insert and pBudCE4.1 vector were
loaded on run on Agarosegel. The bandsatthe right size were cut with a razor blade
and centrifuged at the maximum speed through a glass wool columnto purify the
DNA from the agarose gel. The flow through of the column wasprecipitated in 2
volumes of molecular grade ethanol and 1/10 of 3M sodium acetate and incubated
for at least one hourin - 80 °C. Centrifuge the solution at 15,000xg for 30 minutes to
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pellet the DNA. The pellet was dried and resuspended in 50 ulsterile de-ionised
water.
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Ligation of insert into digested final vector:
Invitrogen Qubit assay kit was used to measure the concentration of the vector
and the insert. The following equation was used to calculate the amount of DNA
required for the ligation reaction:
 
 
ug of vector x Kb size of insert x molar ratio ofinsert = ug ofinsert
Kbsize of vector vector
100 x 2.2 x 3 in74.2 1
Ligation Quantity
pBudCE4.1 vector 3 ul
OBCAM.-Fcinsert 4 ul
Ligation Buffer 2 ul
T4 ligase enzyme 1 ul    
Table: ligation of the insert to the final vector
Overnight incubation of the ligated OBCAM-Fc insert with pBudCE4.1 final
vectorat the ratio of 3:1 the insert to the vector at 14°C with lu] T4 Ligase enzyme
and 4ul buffer follow the manufacturer’s instructions (Invitrogen). Competent
bacteria were transformed with the ligation product and spread on low salt LB agar
plates, and then these plates incubated overnight at 37°C.10 well formed colonies
were grown and screened for OBCAM-Fc-pBudCE4.1 by PCR using Taq
polymerase (Invitrogen) with same forward and reverse primers and in addition to
negative control.
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Plasmid Sequencing:
OBCAM-Fc construct was sent to be sequenced to (Lark) (Cogenics) to
confirm the cloning of OBCAM-Fcinsert into pBudCE4.1 vector (Invitrogen) vector
plasmid using forward T7P primer.
Endotoxin free midi plasmid prep:
The isolation of the endotoxin free plasmid DNA was performed by using
Sigma Gen Elute endotoxin free plasmid midi prep. Up to 250ug was expected
according to the manufacture’s protocol. The transformed competent bacteria were
enucleated into 40 ml LB broth (or low salt LB broth) containing antibiotic and
incubated and shaken at 37°C and 250 rpm. Then, the overnight bacteria culture was
pelleted by spinning at 3000xg for 5 minutes and lysed in a modified alkaline-SDS
procedure. The endotoxins were removed from the clear lysate. Plasmid DNA was
purified through a column in the presence of high salt. After binding and spin
washingsteps, the pure plasmid DNAwaseluted in endotoxin free water.
Ethanolprecipitation:
Two volumes of molecular grade (Sigma) and 1/ 10" volume of 3M sodium
acetate were added to the total volume of endotoxin free plasmid to purify and
concentrate the plasmid. The solution kept in -80°C for 2-24 hours, and then spun for
30 minutes at 15000xg. The dried andprecipitated pellet was resuspendedin 50 ul of
DEPCwater.
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CHO-cell lines Tissue culture:
Production of recombinant chimeric heterodimeric protein:
Transfection of CHO cells:
For transient transfection, CHO cells were cultured in 6 well-plate tissue plate
at cell density of 0.8-1x10° with 13mm glass cover slips in DMEM/F12 plus
10%FCS growth medium for 24 hours incubation at 37°C, 5% CO2 level. Firstly,
ethanol precipitated endotoxin free pBudCE4.1-OBCAM-Fc-myc-His6 (lug/ul)
and/or pcDNA6-CEPU-V5-His6 (1 wg/ul) plasmid were diluted into 150m M NaCl
buffer, briefly, the solution were mixed using vortex and microfuge. ExGEN500
(Fermentas) transfection reagent was addedto the solution at a ratio of 3:1 according
to the manufacturer’s instructions, immediately, the solution of transfection were
vortexed for 10 seconds and incubated for 10 minutes at room temperature then
added to CHOcells drop wise and the plate was rocked vertically and horizontally
and centrifuged for 5 minutes at 90xg. The cells were incubated for 24 hoursat 37°C,
5% CO2 level. The GFP was cloned into pBudCE4.1 vector already under EFal
promoter. Thetransfection efficiency was assessed by counting the numberofcells
that expressing GFP (fluorescent) to the total number of cells (phase) in three
microscopicfields in each coverslip using fluorescence microscope.
For Stable transfection, CHO cells were cultured and transfected as before for
transient transfection. Killing curves were carried out for Blasticidin and Zeocin
antibiotics. The selective antibiotics were added to the growth medium after 48 hours
incubation from the transfection. The cell count should be less than 50% confluency
to increase the efficiency of the antibiotic. Once the transfected cells started to
establish small colonies, these cells were subcloned into a 96 well plate by detaching
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them from the plate using 1% trypsin EDTA. 100 cells were resuspended in 10 ml of
culture medium using haemocytometerin order to grow only single cell in each well
of the 96 well plate.
Transfection of J558L myeloma cells using nucleofector
electroporation (Amaxa):
0.5 ml of supplement that supplied with the kit was mixed gently to
nucleofection solution before nucleofection. JS58L myelomacells were cultured in
5% FCS DMEM growth medium at 37°C and 10% CO2incubator. 2x10° cell/ml
were centrifuged at 90xg for 10 minutes at room temperature and the supernatant was
discarded. 100u1 of nucleofection solution was added to the pellet of the cells.
Immediately, 2ug/ul of endotoxin free plasmid was added to the suspension which
was transferred carefully (no air bubbles) into nucleofector cuvette using special
micropipette supplied with the kit. T-16 nucleofector programme wasselected for
electroporation of J558L myelomacells. 500u1 of pre-warmed medium wasaddedto
the cells immediately after electroporation in the cuvette and thentransferred into 24
well plate for incubation at 37°C and 5-10% CO2. The transfection efficiency was
analysed after 24 hours by counting the cells expressing GFP to the total number of
the cells in three different microscopic fields using the inverted fluorescent
microscope (Leica DM IRS).
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Protein A agarose beads purification of recombinant chimeric
protein:
The culture supernatant of the stably transfected cells were collected after 7-10
days of incubation at 37°C and 5% CO2to purify the recombinant protein. Thetotal
volume culture supernatant was centrifuged for 5 minutes at 3000 RPM in 10 (50ml
universal tube) to get rid of cell debris, then the pH adjusted to pH 8 by adding 100u1
of 2M Tris pH 8 to each tube. 50ul of protein A Agarose beads (Sigma) (100u.g/ml)
were added to each tube, then all tubes were incubated rotating for 2 hours to
overnight at 4°C to allow the beads to interact with the Fc portions of the
recombinant protein. The total volume of culture supernatant was run through a
column, a flow through of the column wascollected to check the efficiency of the
process. The collected beads at the bottom of the column were washed with 100 mM
Tris pH 8, followed by two washes with 10mM Tris pH 8. The protein waseluted in
0.2M Glycine pH 2.5 (Sigma) in fractions, immediately, pH of protein solution was
adjusted by adding 2M Tris pH 8 and checked by pH paper. 21 of each fraction of
protein was dotted and dried on filter paper, then Comassie stain was used to
visualise the concentration of protein in different fractions. 5ml of protein fractions
were collected and concentrated to 1ml of high concentrated recombinantprotein by
using spin column, and then ELISA estimated the concentration of protein.
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Preparation of Antibody coupled beads Column:
(Img) of antibody (ant-myc or anti-V5) (Invitrogen) was coupled with
AminoLink Plus immobilisation kit (PIERCE) using the pH 7.2 Coupling buffer (by
dissolving BupH Pack contents in 500 ml of ultrapure water). The AminoLink Plus
Resin was Suspended by end -over-end mixing, to avoid drawing air into the column,
sequentially the top cap and then the bottom tab were removed, then the column was
centrifuged to remove the storage buffer. The column was washed twice by adding
2ml of coupling buffer pH 7.2. I1ml of either anti-myc or anti-V5 antibodies was
added to the column while the bottom cap was replaced, immediately, 2u] sample of
the solution was saved to compare it with a sample of the supernatant. In the fume
hood, 20 ul of Sodium cyanoborohydride solution (5M) was added to the reaction
slurry, and then the column was incubated for 4 hours at room temperature with
rocking. The column wascentrifuged into a new collection tube with the top cap and
the bottom tab was removed. The flow through of the column and a sample taken
immediately prior to coupling were dotted on filter paper to check that the entire
antibody was coupled with the AminoLink Plus Resin. The column wascentrifuged
to remove the coupling buffer and washed with 2ml of Quenching buffer (1M Tris
HCl, 0.05%NaN3, pH 7.4). In the fume hood, 20u1 of Sodium cyanoborohydride
solution (5M) was added to Iml of Quenching buffer, this solution was added to the
column, which was incubated for 30 minutes with rocking at room temperature.
Carefully, the top cab and the bottom tab were removed and the column was
centrifuged to remove the quenching buffer. The non-coupled antibody was washed
away with 2ml of washing buffer (IM NaCl, 0.05% Na Ns) 4 times. The column was
equilibrated with 2ml ofstorage buffer (washing buffer) twice.
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Anti-mycor anti-V5 column Purification of CO-Fc:
Use either anti-V5 or anti-myc coupled columnto purify CO-Fce from CC-Fc
or OO-myc recombinant proteins. Incubation of 5ml of concentrated CO-Fe (result
from protein A column) within the column 2 hours to overnight at 4°C while
rocking. The column wascentrifuged at 3000 RPM for 5 minutes, and then the flow
through wascollected to check the efficiency of the column. Then the column was
washed 4-6 times with PBS and finally eluted with 0.2M Glycine pH 2.5 in Iml
fractions. ELISA assay wasusedto checkthe efficiency of the column with the flow
through andthe elution of the column.
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Characterisation of heterodimeric recombinant chimeric proteins:
Enzymelinked immunosorbant assay (ELISA):
ELISA assay was used to estimate the concentration of IgLONs recombinant
chimeric proteins secreted by transfected cell lines and to identify the ratio between
the homdomeric and heterodimeric proteins. ELISA assay used 96 well plastic micro
plate (Costar). The first coat was with 50 ul primary antibody either anti-mycoranti-
V5 antibody (Invitrogen) (1mg/ml) (1:300) diluted in 100 mM in NaHCO;buffer pH
9.6 for 2-3 hours incubation at room temperature. 200 wl of 1%BSA in PBS wasused
to block the first layer for 1 hour, followed by three washes with 0.05%Tween20
(Sigma) in PBS. The second layer was 5Oul chimeric IgLONsprotein for 24 hoursat
4°C. The protein was removed and the plate was washed carefully three times with
washing buffer (0.05% Tween20 in PBS). The third layer was 5Oul anti-V5 oranti-
myc HRP-labelled antibody (Invitrogen) (1:500) diluted in blocking buffer for 2-3
hours at room temperature. 3-5 washes with the washing buffer was followed by
incubation with 50-100u1 freshly prepared 0.1mg/ml3, 3’, 5, 5’-titramethylbenzidine
dihydrochloride (TMB)substrate (Sigma), followed by 1mg/ml TMBsubstrate tablet
dissolved in 10 ml phosphate-citrate buffer) per well for 30-60 minutes. The reaction
was stopped with 20 ul of IM H2SO, (Merck).The micro plate of ELISA assay was
analysed by a JBIOLP400 ELISA microplate reader at an absorbance wavelength of
450nm. HRP enzymatic activity was responsible for the colour change in the TMB
substrate; there was a relation between the amount of recombinant protein and the
absorbance wavelength of 450 nm.
Anarbitrary unit (AU/ml) was generated to deal with the quantification using
the ELISA at the linear range of the curve, to measure the concentration of the
recombinant chimeric proteins due to the difficulty in isolation of the heterodimeric
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protein from the CC-Fe and OO-Fe homodimeric recombinant protein that secreted
by CHOstable transfected cell line.
Western blotting:
NuPAGE™(PAGEpolyacrylamide gel electrophoresis) from Invitrogen was
used for Western blotting analysis using Novex gel system. Lithium dodecyl sulphate
(LDS) sample buffer was added to IgLONs recombinant chimeric protein which was
loaded onto Novex ™ 3-8%Tris Acetate polyacrylamide gel and run in NuPAGE™
Tris Acetate buffer (Invitrogen) at 20-30 volts. The loaded proteins were transferred
onto the BioTrace ™(Pall Gelmanlaboratory) nitrocellulose transfer membrane, and
then the membrane was sandwiched between 3M chromatography paper soaked in
0.3 M Tris pH 10.4-bottom buffer and 25mM Tris pH 9.4 top buffer containing 20%
methanol wasusedto transfer sample proteins using a Biorad Trans-Blot ™ semi-dry
cell. The nitrocellulose membrane wasincubated overnight in 150mM NaCl, 10mM
Tris pH8.4, 0.2%Tween 20 blocking buffer and stained with primary antibodies
diluted 1:2000 to 1:5000 in blocking buffer plus 1% BSA, the secondary anti- HRP-
labelled antibodies (DAKO) were used to stain the membrane to detect the primary
antibody. The magic marker (Invitrogen) was used to measure the size of protein.
Peco™ and Femto™ chemi-illuminescence substrates were used to visualise the
protein bands onto Hyper Film ™ ECL (Amersham) chemiluminescent film using
Kodak photo chemicals (Sigma).
Image J software was used to scan the bands of the western blot and then generate
peak for each band. The peaks were cut then the weight of each peak was measured
using the analytical balance to compare the density of the bands
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Dotblotting:
2ul of protein sample was dotted and dried on a nitrocellulose membrane. The
membranewasincubated overnight in 150 mM NaCl, 10mM Tris pH8.4, 2%Tween
blocking buffer. The primary antibody was diluted 1:2000 or 1:5000 in blocking
buffer plus 1%BSA and incubated for 1 hour at room temperature with gentle
rocking. The blot was washed for 30 minutes with 3 changes of blocking buffer. The
secondary anti-HRP labelled antibodies (DAKO) were incubated for 1 hour and
washed for 30 minutes at room temperature. Peco ™ or Femto chemi-illuminescence
substrates were used to determine the concentration of the protein. The blot was
developed on Hyper Film ™ ECL (Amersham) chemiluminescentfilm using Kodak
photo chemicals(Sigma).
Coomassie staining:
Coomassiecheck spelling blue staining solution was used to stain dot blot for
fractions of protein on filter paper for 5 minutes to 1 hour at room temperature with
gentle rocking. Oncethe dots stained, and then incubated in destaining solution with
several changes.
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Primary neuronsculture:
The dissected chick E8 Forebrain tissues were torn into pieces and incubated
in Iml x 0.05% trypsin in HANKS Balancedsalt solution (-) (HBSS) (Sigma) plus
100ug/ml DNAse (Sigma) for 30 minutes at 37°C, 5% CO». These forebrain tissues
were washed in HBSS and followed by a wash with HBSS plus Img/ml soybean
trypsin inhibitor (Sigma) for 2 minutes, and resuspended in DMEM/F12 growth
medium plus Glutamax (Sigma) that contains 1.5%glucose, 100ug/ml transferrin
(Sigma), 100ug/ml insulin (Invitrogen) and 50 units of penicillin/streptomycin
(Invitrogen). Aclar cover slips were coated with 10 mg/ml Poly-L-Lysine in 100mM
sodium borate buffer pH 8.4 for 1 hour and then washed into 24 well plate with
HBSS.Theforebrain cells were dissociated with a polished glass Pasteur pipette into
a single cell suspension. A haemocytometer was used to count the cells that were
distributed into 24 well plate in 0.5 ml per well. Forebrain neurons were cultured in
24 well tissue culture plates at a density of 2x10° cell/ml.
Dissected chick E10 chick sympathetic or dorsal root ganglion tissues were
incubated in Iml of x 0.25% trypsin in HBSS (no EDTA)(Gibco) for 30 minutes at
37°C, 5% CO>. Glass cover slips were coated with 10mg/ml laminin for 1 hour. A
polished glass Pasteur pipette was used to dissociate the cells into a single cell
suspension. A haemocytometer wasused to countthe cells that were distributed into
24 well plate in 0.5 ml per well These cells were washed and resuspended HBSS and
then cultured in L15 glutamax growth medium (Gibco), 50 units of
penicillin/streptomycin (Invitrogen) plus 0.5g methocel that contain 2ml of 30%
glucose, 10% FCS and 5ul of NGF. Dorsal root ganglion or sympathetic neurons
were cultured in 24 well plate at density 1x10° cell/ml.
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Live staining of neurons andcell lines with antibodies:
The cultured neurons were incubated for 2 days at 37°C, 5% CQz level at
density of 2x 10° cell/ml in 24 well plate. These neurons grown onpre-coatedaclar or
glass cover slips with Poly-L-Lysine or laminin (Sigma) (10yg/ml), whereas IgLON-
transfected cell lines; CEPU, OBCAM, LAMP, CO and CL CHOcell lines were
cultured at 5x10* in 24 well plate on glass cover slips. These cover slips were
extracted carefully from each well, 30u1 of rat antiCEPU-1, anti-OBCAM oranti-
LAMPantibodies diluted 1:50 in 0.12 M phosphate pH 7.4 buffer 1%BSA were
incubated at room temperature for 20 minutes. The cover slips were washed three
times in HBSS. 30 ul of anti-rat Alexa Fluor 488 was used as secondary antibody
(Invitrogen) diluted 1:200 in the same buffer and incubated for 30 minutes. The
cover slips were dip washed again three times in HBSS. 4% paraformaldehyde
(Sigma) was usedto fix the live stained neurons or cells. These cover slips were dip
washed three times in HBSS and one final wash in water, and then dried at room
temperature.
In the case of IgLON-Fc chimeric recombinant protein, CEPU-1-Fc, OBCAM-
Fe or CO-Fc, 30ul of 1: 100 diluted anti-human Fc fluorescent-labelled antibody
(Jackson), mouse anti-myc antibody or anti-V5 antibodies (Invitrogen) diluted 1:50
in the same buffer. 30 wl 1:250 anti-mouse 488 Alexa Fluor (Invitrogen) was used as
secondary antibody.
The lived stained cells were fixed with 4% Paraformaldehyde (Sigma) in PBS for 5
minutes, followed by three washes in HBSSandfinal wash in water to remove in
residual paraformaldehyde. These cover slips were dried and mounted in Dako™
mounting medium onglassslides.
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Neurite outgrowth assay:
Nitrocellulose membrane solution was prepared by resuspending 2cm x 3cm
square of Protran BA 85-nitrocellulose membrane (Schleicher & Schuell) in 2ml
tissue grade methanol (Merk). This solution was used to coat 13mm glass coverslips
with 20 ul per each coverslip for 1 hour at room temperature. These coverslips were
coated with 20u1 of (100ug/ml) protein A (Sigma) for an hour. Followed by,
spreading of 30ul of (10mg/ml) Poly- L-Lysine for fore brain neurons or laminin for
dorsal root ganglion and sympathetic neurons diluted in100mM sodium borate buffer
pH 8.4 (FB) or PBS (DRG or sympathetic ) per coverslip and then incubated for 1
hour at room temperature. 1% tissue culture grade BSA (Sigma) in PBS wasused to
block the cover slips for 1 hour. Three cover slips were coated with 30ul
(7OOAU/ml) of CO-Fc chimeric protein per coverslips for 1 hour. In parallel, three
cover slips were coated either with CEPU-Fc or OBCAM-Fc chimeric proteins
(100ug/ml) as control. All cover slips were washed with HBSS in 24 well plate
before adding dissociated neurons at density of 2 x10° cell /well and incubated at
37°C, 5% CO> for 24 hour in the medium. The neuronswith their neurites were fixed
with 4% Paraformaldehyde in 0.12 M phosphate buffer pH 7.4. The neurons were
stained with 1% weight: volume Cresyl violet crystals (Sigma) in PBS for 5 minutes
to visualise the neurites. These cover slips were washed with HBSS, and mounted
with DAKO medium. The percentage of the neurite outgrowth was measured by
counting the numberof the neurons with extended neurite to the total numberof the
neurons. There were certain criteria for counting the neurons, only the single neurons
were counted. Leica’s camera and software were used to take photographs. These
experiments were repeated three times and then PRISM software wasusedto analyse
these data.
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Removal of GPI-anchored proteins by Phosphoinositol specific
phospholipase C (PI-PLC) treatment:
For immunofluorescence, IgLONs were removed from the surface of
forebrain neurons by treatment with 100m U /ml Phosphoinositol specific
phospholipase C (PI-PLC)(Invitrogen) in forebrain medium for | hr. Cells were then
stained as described previously.
For neurite outgrowth assay, they were pre-treated in suspension prior to
plating for 1 hour at 37C and 5%CO2level in FB medium with 100m U /ml PIPLC.
Neurons werecultured onto 24 well plate with 13mm coverslips coated with various
substrates as described previously in medium that contain 50 m U /ml PI-PLC
(Invitrogen).
Tissue frozen section:
E 18 chick retina was dissected and fixed with 4% Paraformaldehyde for 2
hours at room temperature. The fixed tissues were incubated consecutively in 6%,
12%, and 18% sucrose in 0.12M Na phosphate buffer pH 7.4, with gentle mixing
until the tissue sank to the bottom of the tube. These tissues were cut and mounted in
Cryo-M-Bed (Bright instruments, UK) on cork discs. Isopentane suspension over
liquid nitrogen wasusedto freeze the tissues. The frozen tissues were stored at -80°C
for further use. Cryostat (Bright) was used to cut 12-15um sections; they were
adhered to subbed glass slides. These slides were precoated with subbing solution
which was prepared by stirring water with gelatin (1.5%) at 60°C. Chromic
potassium (0.1%) sulphate was addedto gelatin once dissolved and cooled. Then add
ethanol (30%) and acetic acid (7%).The slides were dipped into subbing solution and
drained on paper andthenair dried.
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Fluorescent microscopy and photography:
Both fluorescent (Leitz DMIRB)and inverted fluorescent Leica microscopes
(DM IRB) models wereusedto visualise the stained tissue and cells. Oil immersion
lenses with different objectives were used to examine the samples. Photographs were
captured with a Leica’s digital camera and analysed with Leica’s package software.
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Chapter Three
Generation of OBCAM-Fc-myc-His6
construct in pBudCE4.1 Vector
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INTRODUCTION:
In this chapter, the aim was to generate a pBudCE4.1-OBCAM-Fc-myc
construct and test it by transient transfection of CHO cells followed by Western
blotting to characterise the secreted proteins to ensure that each chain is formed. A
previously generated pcDNA6-CEPU-Fc-VS construct would also be tested.
Following double transfection of CHO cells with each construct ELISA assays will
also be used to show CO-Fc exists as a complex and to determine the ratio between
CO-Fc heterodimer and OO-Fc and CC-Fc homodimeric recombinantprotein.
A doubly transfected CHO cell line expressing both CEPU-1 and OBCAM
inhibited the initiation of neurite outgrowth of E8 Forebrain neurons, while no
inhibition occurred with the singly transfected CHO cell lines (figure 1.9). This
evidence suggested that IgLONscould havedifferent activities when they exist in the
dimeric form of IgLON (DigLON). DigLONs are formed by a combination of the
two different members of the group. This provided the basis for the preparation of a
cell line that secrets both proteins CEPU-Fc and OBCAM-Fctogether. Both proteins
will be secreted into the medium instead of being attached to the surface of the CHO
cells by a GPI anchor. Loss of the attachment to the cell membrane will result in
secreted proteins. The secreted proteins can be isolated, concentrated and
manipulated and hence will allow experiments not possible with the proteins
expressed on the surface of CHO cells. In addition, assembly of CEPU-1 and
OBCAMas complex will ensure that they are at close proximity. Their detection in
the medium will be difficult without something that can be used as a label for the
heterodimer.
There are many routes to label the CEPU-OBCAM heterodimer;direct labelling with
antibodies is one of the choices. However, anti-CEPU-1 and anti-OBCAM rat
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antiserum cannotbe used dueto cross reactivity. Another option is cloning of CEPU-
1 and OBCAMinto a vector that has two epitope tags under different promotors,
such as the pBudCE4.1 vector that has a V5 epitope tag under EF-a1 promoter and
myc epitope tag under CMV promoter. However, the expression of each chain might
be unbalanced dueto differing strengths of the two promoters. Therefore, cloning of
each one alongside an epitope tag into two separate plasmids with specific antibiotic
resistance will label OBCAM and CEPU-1! with different tags. Cloning of CEPU-Fc
into pcDNA6 that has V5 epitope tag and is resistant to both Ampicillin and
Blasticidin antibiotics was carried out previously (kind gift from M. Lyons &
D.Moss). OBCAM-Fc will be cloned into pBudCE4.1 that has a myc epitope tag
under CMV promotor. pBudCE4.1 is resistant to Zeocin antibiotic. This plasmid also
has the advantage of having GFP cloned into the second polylinker under the EF]
promoter.
These epitope tags will be used in characterisation of the heterodimer by
different methods such as ELISA, dot blot and Western blotting. They can be used
also in the detection and interaction of the heterodimer. Each protein can be
identified separately because there is no cross reactivity between these tags.
Furthermore, Protein A agarose beadswill be used in purification of the recombinant
chimeric protein using the humanFc of each protein. CO-Fc IgLON heterodimer will
be used as a tool to identify the putative receptor complex on the surface of the
neuron.
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RESULTS:
The first step in the preparation of the epitope-tagged OBCAM-Fc was to
clone OBCAM-Fc into pBudCE4.1 (figure3.1) such that the myc-His6 was in frame
with the terminal exon of the human Fe. Primers were designed to achieve this as
described in figure (3.2). OBCAM-Fc was amplified from pcDNA3 using proof
reading Taq polymerase in three dilutions, 1:10, 1:100, and 1:1000 as shown in
figure3.3. The use of proof reading Taq polymerase was used to avoid any
mismatches that happened with the ordinary Taq polymerase. The PCR product
obtained from the most diluted sample (1:1000) was cloned into pCRII TOPOas an
intermediate vector using the T/A cloning kit (figure 3.4). Both pCRIIT TOPO and
pcDNA3 are resistant to Ampicillin while pcRIJ TOPO is also resistant to
Kanamycin. DH5a-T1 competent bacteria were transformed with T/A cloned product
and colonies selected with Kanamycin. Ten colonies were screened and five colonies
have the insert when screened by PCR with the forward and reverse primers but
using Taq polymerase (figure3.5). The best colony that contains OBCAM-Fcinsert
was grown in overnight culture of LB broth with kanamycin antibiotic, and then a
Miniplasmid prep wascarried out. This insert was double digested out of the pCRII
vector with HINDIII and Xbal restriction enzymes(figure 3.6). These restriction
sites were incorporated into the primers for this purpose. The insert was cut and
isolated from the Agarose gel using glass wool tubes to get high and pure yield of
OBCAM-Fc that is needed for the ligation with digested pBudCE4.1vector.
pBudCE4.1 plasmid was ligated with the insert and used to transform DH5a1T
competentbacteria; colonies selected in the presence of Zeocin. These were screened
by PCR to confirm the cloning of the insert into the final vector (figure3.7) and
figure 3.8 showsthe plasmid preparation from one colony.
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In figure 3.8, plasmid from a miniplasmid preparation was run on a 1%
Agarose gel and a band for OBCAM-Fc in pBudCE4.1 plasmid was observed.
pBudCE4.1 was double digested with the same restriction enzymes as before to
confirm the cloning ofthe insert into pBudCE4.1 final vector (figure3.9).
The plasmid was sequenced and the sequence of the OBCAM-Fc construct
(figure3.10) was blasted at www.ncbi.com and the results confirmed that the
sequence had more than 98% identity with chick OBCAM hence confirming the
insertion of the correct sequence.
The next step is to test whether the two constructs code for OBCAM-Fc and
CEPU-Fc respectively including the appropriate epitope tag by single transient
transfection of CHO cells. Single transfection of CHO cells with either pcDNA6-
CEPU-Fc-V5 construct or pBudCE4.1-OBCAM-Fc-myc construct was carried out
using ExGene500 (Fermentas). Firstly, the transfection efficiency of OBCAM-Fc
construct in pBudCE4.1 was confirmed by the expression of GFP because GFP was
also expressed by the same plasmid. Figure 3.11 shows a phase photomicrograph of
for a group of cells and the corresponding fluorescent photomicrograph shows a
subset of the cells are green due to GFP expression of pBudCE4.1 (figure 3.11). The
efficiency of the transfection was about 30%. After 7 days, the medium off the CHO
cells transiently transfected with CEPU-1-Fe or OBCAM-F¢constructs wascollected
and spun to remove cell debris and then the chimeric proteins were concentrated with
protein A Agarose beads. Western blotting and ELISA assay were used to test the
presence of both CEPU-1-Fc-V5-His6 and OBCAM-Fc-myc-His6 chimeric
recombinant proteins. Figure 3.12 shows a western blot of the medium from the
transient transfected CHO cells. The first blot was stained with rat anti-CEPU-1
antisera, anti-rat HRP labelled, and the second one wasstained with mouse anti-V5
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antibody and anti-mouse HRP labelled antibody. Both bands at the right size
(85KDa) and confirm that CEPU-Fc-V5-His6 molecule was formed. The 3" and the
4" blots stained with rat OBCAM antisera and secondaryanti-rat HRP and anti-myc
antibody with secondary anti-mouse HRP-labelled which means that OBCAM-Fc-
myc-His6 wassecreted in the medium.
In figure 3.13, a curve represents an ELISA assay on 10 fold concentrated
CEPU-Fc-V5-His6 obtained bytransient transfection and concentrated using a Spin
column. Anti-V5 antibody was used to capture the V5 tag on the first chain of the
molecule, which was then detected using the second V5 tag on the other chain of the
molecule using anti-VSHRPlabelled antibody as described in the diagram. As shown
in this figure, there is a relation between the dilution factor of the protein and the
absorbance at 450mm optical density. The dilution range was between 0.01 and
0.001 dilutions. The linear range was between 0.001 to 0.005 dilutions.
The ELISAassay on 10 times concentrated OBCAM-Fc-myc-His6 supernatant
obtained bytransient transfection is shownin figure 3.14. The diagram explains how
anti-myc captures the recombinantprotein and the anti-myc HRPdetects the second
epitope tag. There is a relation between the concentration of the protein and the
absorbance at OD 450mm. The protein was diluted in serial dilutions; the linear
range was between 0.1 to 0.001.which differs from the linear range for CEPU-Fc-
V5-His6. This might be due the detection sensitivity of antibodies.
Having demonstrated that both constructs were correct and specified the
synthesis of the correct epitope-tagged proteins the next step was to carry out a
transient double transfection of CHO cells with both constructs to test for the
formation of CO-Fc heterodimer.
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CHOcells were transiently co-transfected with both pcDNA6-CEPU-1-Fc-V5
and pBudCE4.1-OBCAM-Fc-myc constructs in order to test whether the
heterodimeric protein is assembled in these cells. The medium was collected from
the co-transfected CHO cells after 7 days. The neat, 1+4 and 1+7 dilutions were
assayed in an ELISA that revealed that CO-Fc heterodimeric protein gives high
absorption at 450mm OD, while CC-Fc and OO-Fc give low absorption in all
dilutions (figure 3.15).
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DISCUSSION:
The aim of this chapter wastotest the viability of constructing a heterodimeric
protein using the Fc human IgG domain, by transient single and double transfection
of CHO cells with pBudCE4.1-OBCAM-Fc-myc and pcDNA6-CEPU-Fc-V5
constructs.
Western blotting confirmed that the epitope tags had been cloned into the
plasmids in frame and that CEPU-1 and V5 formed part of the same polypeptide
chain as did OBCAM and myc. This was confirmed by the presence of CEPU-Fc-
V5-His6 and OBCAM-Fc-myc-His6 followingtransient transfection of CHOcells.
The ELISAassay was developed in order to be able to detect CO-Fe as well as
the two homodimers. These assays provedthat transient double transfected CHOcell
secreted CO-Fc heterodimer, CC-Fe and OO-Fc homodimers
In the ELISA assay, the homodimers may be underestimated due to a
possibility of capture of both tags instead of one tag only of the homodimer. This
leaves no chance for the HRP-labelled antibody to detect the second tag of the
homodimer. For example, OO-Fc homodimer has two myc tags, which may be
detected by the anti-myc antibody at the same time. In this case, the anti-myc-HRP
labelled antibody will not be able to detect the second myc tag of the homodimer. In
contrast, this cannot happen for CO-Fc heterodimer due to the presence of two
different tags on the complex; myc and V5 tags. For example, the myc tag will be
detected by the primary anti-myc antibody where the secondary anti-V5-HRP
labelled antibody will detect the V5 tag of the other chain of the complex.
Furthermore, in double transfection; there was variability in the detection of
CO-Fc according to the orderof the antibodies. For example, when anti-V5 antibody
used as the capture antibody instead of anti-myc antibody and anti-myc-HRPlabelled
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antibody used as the detection antibody instead of anti-V5 HRP-labelled antibody,
the apparent concentration of CO-Fc wasdifferent. This point confirmsthat anti-V5-
HRPlabelled antibody was mostsensitive.
Following confirmation that CO-Fc exists as heterodimer using ELISA assay,
the next step is the generation of a stable cell line, which produces CO-Fc
heterodimeric chimeric recombinantprotein.
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Comments for pBudCE4.1
4595 nucleotides
Figure 3.1: pBud vector plasmid map
The map of pBudCE 4.1 (4595bp) vector (Invitrogen) shows the cloning site of
OBCAM-Fc downstream under CMV promoter between HIND III and Xbal
restriction sites. This location ensured that OBCAM-Fc was synthesised in frame
with myc epitope tag. On the other side, GFP was cloned downstream under EF-1a.
promoter.
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Startcodon Xba1site
Forward primer Reverse primer
Figure 3.2: Modified sequence of OBCAM-Fc primers
This diagram describes the modified sequence for OBCAM-Fc showing the forward
modified primer (blue) followed by the start codon (yellow) of OBCAM-Fc(red).The
reverse primer which include Xba!site (in black) is located before the stop codon of
the Fc sequence. This allows the myc-His6 tag of the pBudCE4.1 to be added in
frame to the OBCAM-Fc sequence.
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Figure 3.3: PCR amplification of OBCAM-Fc in peDNA3
1% agarose gel shows three bands representing the PCR products produced using
three dilutions 1:10, 1:100 and 1:1000 of the original OBCAM-Fc in pcDNA3
plasmid as template. PCR products prepared using pfx Taq polymerase (Invitrogen)
are located at the expected size (2.2Kb). Both forward and reverse primers were
used at annealing temperature 56°C and extension temperature was 68°C. The most
diluted plasmid wasselected (1:1000 dilution).The negative control showed no DNA
band.
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Figure 3.4: TA cloning of OBCAM-Fc PCR productinto pCR® Il-TOPO®
OBCAM-Fc construct was cloned into cloning site downstream under lacZ promotor
of pCR® II-TOPO®asintermediate vector using T/A cloningkit (Invitrogen).
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Figure 3.5: PCR screen for OBCCAM-Fc in pCRII TOPOvector
An agarose gel (1%) shows the results of the PCR screen using Taq polymerase
(Sigma) for 10 selected colonies of transformed DH5-a-T1® competent bacteria.
Colonies were selected on Kanamycin LB agar plates at 37°C overnight following
TA cloning of OBCAM-Fc into pCRII TOPO intermediate vector. There were two
different sizes of PCR productsin five colonies (1, 2, 3, 6 and 9). The No.6 colony
was selected which was strong and at the right size for Miniplasmid prep (Sigma).
Therec was no DNA bandin negative controllane.
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Figure 3.6: Double digestion of OBCAM-Fc from the pCRII vector
A) 1% Agarose gel shows the products of the double digestion of OBCAM-Fc pCRII
vector using Hind III and Xbal restriction enzymes. In the I“ lane 1Kb marker, in
the 2"4 lane, undigested OBCAM-Fcin pCRII. In the 3” lane, there are two bands,
the plasmid backbone pCRII andthe insert OBCAM-Fc
B) OBCAM-Fc was prepared from the 1% Agarose gel ready for the next cloning
step. The three insert bands were combined.
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OBCAM-F¢insert 3Kb2Kb
 
Figure 3.7: PCR screen for OBCAM-Fcin pBudCE4.1
1% Agarose gel shows PCR screen using Taq polymerase (Sigma) for 10 selected
colonies which have been grown on Zeocin low salt LB agar overnight. Five colonies
with the right size (2.2Kb) were selected as shown for Miniplasmid prep (Sigma).
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1Kb marker OBCAM-Fc(pBud)
 
Figure 3.8: Miniplasmid prep of OBCAM-Fc-myc-His6 in
pBudCE4.1 final vector
1% Agarose gel shows a band of OBCAM-Fc-myc-His° in pBudCE4.1 at the right
size (6Kb). It was obtainedfrom a Miniplasmid prep (Sigma) of an overnight culture
of the colony number(3)
80
1Kb_ undigested digested
Kb —> <— OB-Fcinsert
 
Figure 3.9: Confirmatory double digestion of OBCAM-Fc from
pBud CF4.1
1% Agarose showsin the 1" lane markers, lane 2, undigested OBCAM-
Fc in pBudCE4.1 at 6 Kb and 3” lane, the OBCAM-Fc (2.2Kb) and
pBudCE4.Iplasmid digested with HINDIII and Xbal restriction enzyme
(Invitrogen).
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TEDUUEECTECUEEEPEUEEUL UPLEEUUGCCACCTTCCCCAAAGCTATGGACAACGTGACTG
TGCGGCAAGGGGAGAGTGTC-CGCTCAGGT 161
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GCGGCAAGGGGAGAGTGCCACGCTCAGGT 2035557
GTGGATGACAGGGTGACGCGGGTAGCGTGGTTGAACCGCAGCACCATCCT
TEEPETEULUPLLEEPER,GACAGGGTGACGCGGGTAGCGTGGTTGAACCGCAGCACCATCCT
TTATGCTGGCAATGACAAGTGGTCTATAGACAACCGCGTGGTCATCCTCTCCAACACTAA
PTETEEEEEEEEE EEE EEE EEE
TTATGCTGGCAATGACAAGTGGTCTATAGACAACCGCGTGGTCATCCTCTCCAACACCAA
AACCCAGTACAGCATCAAGATCCACAACGTGGATGTGTACGATGAGGGGCCCTACACCTG
HLLEEEEEE EEE EEE Ed
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CTCCGTGCAGACAGACAATCACCCCAAAACATCGCGCGTCCACCTCATCGTGCAAG 2164697
TGCAAGTCCCCCCTCAGATTGTCAACATCTCATCAGACTTCGCCGTGAACGAAGGCAGCA
HEL TPL PEEP EEE EEE EE EEE EEE EEE
TGC -AGTCCCCCCTCAGATTGTCAACATCTCATCAGACATCACCGTGAACGAAGGCAGCA
CTCATGTGCTTGGCCTTTGGG -G- CCGGAGCCCACTGTCACGTGGCGGCATC
TITTLE LUELLA LTTE EEE EEE EEE
TGTGCTTGGCCTTTGGGAGGCCGGAGCCCACTGTCACGTGGCGGCATC
TCTCTGGGAAAGG 517
LITTLE LETTE
TCTCTGGGAAAGG 2151259
AGGGCAAGGCT GGAGATCA
PEEVETiCHUTEUCUHEUTCUCULE
ATGAGTGCAGTGCTGTCAATGACGTGGCCGTCCC 619
PETPLEPLTUITEPLU HTTTL TILLAAAGTGCAGTGCTGTCAATGATGTGGCTGTCCC 2150971
Figure 3.10: OBCAM-Fcconstruct blasted against OBCAM
sequence:
446
2151332
504
2151272
574
2151016
OBCAM-Fc sequence (Query) whichis cloned into pBudCE4.1. This is sequenced by
LARK Cogenics with T7P forward primer. It was blasted in www.ncbi.com website
and the match showed more than 98% similarity to the OBCAM sequence(subject).
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Figure 3.11: Transfected CHO cells with OBCAM-Fc-myc-His6
(pBudC4.1) (GFP)
Phase andfluorescence photographs show CHOcells that are transiently transfected
with pBudCE4.1 where OBCAM-Fcconstruct was cloned under CMV promoter and
GFP under EFal promoter. GFP was used to measure the transfection efficiency of
pBudCE4.1 (50um scale bar).
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Figure 3.12: Western Blot for transient single transfection for
OBCAM-Fc-myc-His6 and CEPU-Fc-V5-His6 respectively
The first blot was stained with rat anti CEPU-1 antisera (1:5000) with
secondary HRP-labelled anti-rat antibody 1:5000, the second blot
stained with mouse anti-V5 antibody 1:2000 with secondary HRP-
labelled antimouse antibody 1:2000, both shows CEPU-Fc-V5 protein
was secreted by singly transfected CHOcells. The third blot was stained
with rat anti-OBCAM antisera 1:5000 with secondary anti rat HRP-
labelled antibody 1:5000, the last blot stained with mouse anti-myc
antibody (1:2000) and secondary anti-mouse-HRP-labelled (1:2000).
Both show OBCAM-Fc-myc-His6 chimeric protein was secreted by
singly transfected CHOcells.
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Figure 3.13: CEPU-Fc-V5-His6 Transient Single transfection
A) A diagram to describe the interaction between the anti-V5 antibody and anti-V5
HRP labelled antibody with CEPU-Fc-V5-HIS6 recombinant protein in ELISA
assay.
B) A figure shows a curve for the relation between dilutions of CEPU-Fc-V5 His6
and the absorption at 450 nm optical density. CEPU-Fc-V5-His6 protein was diluted
from 0.1 to 0.001 dilutions. (n=3)
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Figure 3.14 OBCAM-Fc-myc-His6:transient single transfection
A) A diagram to describe the interaction between anti-myc antibody and anti-myc
HRP labelled antibody with OBCAM-Fc-myc-His6 recombinant protein in ELISA
assay.
B) A figure shows a curveforthe relation between dilutions of OBCAM-Fc-myc-His6
recombinant protein and the absorption capacity at 450 nm OD. (n=3)
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Figure 3.15: Transient double CEPU-OBCAM-Fctransfection
A) Diagrams describe the interaction between antibody (1:300) and HRP labelled
antibody (1:500) with CO-Fc, OO-Fc and CC-Fc recombinant proteins in ELISA
assay.
B) A figure shows a curve for the relation between the dilution of CO-Fc-myc-His6
recombinant protein and the absorption capacity at 450 nm OD. There are three
different dilutions, neat (green bar), 1+4 (red bar) and 1+7 (blue bar). CO-Fc
heterodimeric chimeric protein concentration is more than six fold more than the
concentration of either OO-Fc or CC-Fc homdimeric proteins. (n=3)(SD=CO-Fc
(0.025502, 0.08778, 0.003786) OO-Fc (0.008718, 0.011136, 0.007506) CC-Fc
(0.004359, 0.003055, 0.001528) respectively.
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Chapter Four
Production and Characterisation of
CO-Fc heterodimeric recombinant
protein
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INTRODUCTION:
In this chapter, a stable cell line transfected with both pcDNA6-CEPU-Fc-V5
and pBudCE4.1-OBCAM-Fc-mycconstructs will be prepared to generate the CO-Fc
heterodimeric recombinant chimeric protein. There are many types of cells that can
be used to establish this cell line. For example, CHO cells or mouse J558L myeloma
cells have been used previously. However, the amount of the protein synthesised by
the CHOcells is less than the amountof protein that is produced by the myelomacell
line. In addition, the myelomacell line is normally used for the synthesis of
antibodies and ourprotein is similar to an antibody in structure. They are considered
as suspensioncell type; therefore, a miniperm bioreactor can be used toscale up the
concentration of the protein by accumulation of the protein in the culture medium.
On other hand, the disadvantage of the myelomacell line is that they are difficult to
transfect especially with two plasmids (Lodge et al., 2000), while the CHO cell line
is easy to transfect and has good growth. In case of adherentcell type such as CHO
cells, a scale up method by expansion overlarge culture area can be used to get the
appropriate yield of the recombinantprotein. The aim is to attempt to make a doubly
transfected cell line using mouse J558L cells but CHO cells can be used if necessary.
The cells doubly transfected with both pcDNA6-CEPU-Fc and pBudCF4.1-
OBCAM-Fc constructs will be screened by using antibiotic resistance in both
pcDNA6 plasmid and pBudCE4.1 plasmid. pcDNA6 has Blasticidin antibiotic
resistance while the pBudCE4.1 has Zeocin resistance. Use of both antibiotics will
select the stably transfected cell line.
Statistically, a mixture of heterodimeric and homodimeric chimeric
recombinantproteins is expected to be produced by the double transfected cell line,
with a ratio of two for CO-Fc heterodimeric protein to one for each of OO-Fe and
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CC-Fc homodimeric proteins (2:1:1 ratio). In the previous chapter, the outcome of
the transient double transfection of CHO cells was successful, where the ratio of CO-
Fc heterodimer to the CC-Fe or OO-Fe homodimers was more than that expected.
However, this ratio might be variable according to the efficiency of the transfection.
It may therefore be necessary to purify the putative CO-Fc heterodimeric
protein of the contamination caused by homodimeric proteins. Anti-myc and anti-V5
antibodies can be coupled with the beads to assemble affinity columns that can be
used in purification of the CO-Fe heterodimeric protein from the CC-Fe-V5 and OO-
Fe-myc homodimeric recombinant chimeric proteins.
Characterisation of CO-Fc heterodimeric chimeric recombinant proteins will
be required. Firstly, screening of the master clone of the transfection by dot blotting
will ensure that both chains of the protein are secreted by the doubly transfected cell
line. The ELISA assay is a sandwich type of ELISA using anti-myc antibody and
anti-V5-HRP labelled antibody to detect CO-Fc as a complex. In addition, Western
blotting will be used to identify the size of protein. Secondly, characterisation of the
ratio of CO-Fc heterodimeric protein to the CC-Fe and OO-Fce homodimeric protein
that are secreted bythe cell line using ELISA will be necessary.
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RESULTS:
Killing curves were carried out for wild type CHO cells at 1x10° cell/ml and
J588L mouse myeloma cells at 12x 10° in 24 well plate at 50% confluency with
Blasticidin and Zeocin at different concentrations for one week of incubation; the
best concentration was 200ug/ml for Zeocin and 5 ug/ml for Blasticidin. Each
antibiotic killed about 60% of the cells during the first three days (figure 4.1).
Usually the process of generation of the stable cell line takes a long time, so a higher
concentration of the antibiotic might affect their growth especially when both
antibiotics are used together.
Because of the advantages of the mouse J558L myelomacell line, transfection
was attempted first, using the nucleofection method (Amaxa). Initially, single
transient transfections with pBudCE4.1 were carried out to compare different
programmesand buffers. The conclusion was that T-016 was the mostefficient
buffer (data not shown). Then, double transfection with both plasmids (pcDNA6-
CEPU-Fc-V5 and pBudCE4.1-OBCAM-Fc-myc) was carried out by using T-016
programme on J558L myelomacells at cell count 2x10° cell/ml in the Amaxa
cuvette. The electrporated cells were transferred immediately to a 24 well plate and
incubated for 2 days at 37°C 10 % CO,andthentransferred to a 6 well plate at which
point both Zeocin and Blasticidin antibiotics were added to select for the co-
transfected cells. pBudCE4.1 has two separate polylinkers into which OBCAM-Fc
sequence was cloned under the CMV promotor and GFP sequence under EFal
promotor (figure 3.2). Using an inverted fluorescence microscope, the transfection
efficiency (20%) wasassessed by counting the numberof green cell that expressing
GFP of pBud plasmid. Most of the non-transfected cells died after few days in
selection medium whereasthetransfected cells started to grow in colonies.
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The transfected cells were subcloned into two 96 well plates (100cell/ plate-
1000cell/plate) in half the concentration of antibiotics used previously to encourage
the cell growth. After one week of incubation, both plates were screened for
pBudCE4.1-OBCAM-Fc transfected colonies using the inverted fluorescence
microscopy since GFP was expressed under the second promoter of the pBud
plasmid. Next dot blots were used to screen the transfected colonies using anti-myc
and anti-V5 antibodies (figure 4.2). Only nine colonies expressing OBCAM-Fc-myc,
CEPU-Fc-V5 and GFP and displaying good growth were transferred into a 24 well
plate. In figure 4.3, dot blot for supernatants of clones thought to express CO-Fc
were stained with both anti-V5 and anti-myc antibodies to check the stability of
expression of both chains. However, some clones showedstable expression of both
chains while others lost either CEPU-Fc-V5 or OBCAM-Fc-myc chain. The ELISA
assay was used to test the existence of the CO-Fc heterodimer complex and to
estimate the ratio between heterodimeric and homodimeric protein using anti-myc
and anti-V5 antibodies. In figure 4.4, the ELISA revealed that the concentration of
produced protein from the myeloma was low and showedthat the myelomacells had
failed to form the dimeric protein. These results suggested these cells were unable to
assemble the CO-Fc heterodimer complex. This might be due to difficulties in co-
transfection with both plasmids or in dimeric protein formation. Therefore, CHO
cells were chosen to establish the stable CHOcellline.
Figure 4.5, showsthe steps required for double transfection of CHO cells in 6
well plate with both pcDNA6-CEPU-Fe and pBudCE4.1-OBCAM-Fc using
ExGen500 transfection reagent. Transfection efficiency was again monitored by the
numberofcells expressing GFP comparedto the total numberofcells counted across
three microscopefields. The transfected cells survived due to the resistance to both
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Blasticidin and Zeocin antibiotics. Care was taken to ensure that both antibiotics
were effective by transferring cells to a larger dish to keep the numberofcells below
50% confluency. The resistant transfected colonies were established and grown in
the selective antibiotic medium and then subcloned in two 96 wellplates (figure 4.6).
Then 24 clones were expandedin a 24 well plate and were screened by ELISA assay
for CO-Fc. There was sufficient medium to screen for CO-Fc in parallel to OO-Fc
and CC-Fe in the medium of 24 well plate. The assay for the best clone out of 24
clones revealed that the concentration of both OO-Fe and CC-Fce homodimeric
proteins was higher than the concentration of CO-Fc heterodimeric protein (figure
4.7). In view of previous results with transient double transfections in the previous
chapter, a second round of subcloning wascarried out in two 96 well plates, the first
one with 100cell/plate and the other with 200cell/plate.
The 96 well plates were screened for single green colonies using the inverted
Leica fluorescent microscope. A neat sample of medium from each positive well was
used to characterise the supernatant of the transfected colonies. The medium was
tested by dot blot to identify cells or wells that produce CEPU-Fc-V5-His or
OBCAM-Fc-myc-His6 using anti-V5 and anti-myc antibodies. Dot blot assays
showed that some of these clones secreted equal amount of both proteins and others
that secreted unequal amountof each protein (figure 4.8). The next question was did
these proteins exist as a complex and what is the ratio of CO-Fc heterodimeric
protein, CC-Fe or OO-Fe homodimeric proteins? ELISA was used to answerthis
question, by characterising neat samples of the supernatant secreted by the
previously mentioned clones in 96 well plates. To identify the CO-Fc complex anti-
myc antibody wasusedasfirst layer to capture the myc tag of the OBCAM-Fe chain
whereas the anti-V5-HRP labelled antibody was used to detect the V5 tag of the
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other chain of the molecule which is CEPU-Fc. ELISA assay revealed that most of
the selected clones secreted CO-Fc heterodimeric protein. The concentration varied
from the maximum, which was 1D6 clone with 0.6 OD to IGI2 clone which
produced the lowest concentration just above zero OD. There was only one clone
that did not produce CO-Fe whichis IE11 (figure 4.9).
In figure 4.10, all the previously tested clones in 96 well plates were
transferred to 24 well plates and allowed to grow for 2 days until they become
confluent, and then analysed again by ELISAto identify the ratio between the CO-Fe
heterodimeric protein and the OO-Fc or CC-Fe homodimeric proteins. Some clones
such as ID1, ID6, IH3, I1G4, IIG7, ITH9 and ITH11 secreted high concentration of
CO-Fc butstill there were variable concentrations of OO-Fc and CC-Fc secreted by
these clones.
The above-mentioned clones were transferred into six well plates; the
supernatants were recheckedforthe stability of the secretion of CO-Fc heterodimeric
protein against the OO-Fe or CC-Fc homdimeric proteins. ID6 clone when assayed
for CO-Fe gave an OD of 1.3; while CC-Fe gave an OD of 1.2 OO-Fe was 0.8 OD.
This clone had the highest concentration of CO-Fc. The ID1 produced almost the
same concentration of CO-Fc and CC-Fc, which was about 1.00D, and OO-Fc was
about 0.8 OD.Therest of the clones produced CO-Fc about 1.0 OD, OO-Fc about
0.8 OD and CC-Fc around 0.6 OD(figure 4.11).
Six clones that secreted higher concentrations of CO-Fce and lower
concentrations of OO-Fce or CC-Fc were transferred into small sized flasks. At this
stage, IIG4 was considered the best clone because the CO-Fc concentration was
about 0.9 OD, OO-Fe and CC-Fc about 0.5 OD. Although, ID6 produced the highest
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concentration of CO-Fe which was about 1.1 OD, the problem wasthe concentration
of CC-Fc was about 0.8 OD which was consideredto be too high (figure4.12).
Finally, IIG4 clone wasselected to be the best clone according to the expected
ratio(2:1:1) that produced the CO-Fc heterodimeric recombinantprotein at about 1.0
OD with a contamination with CC-Fc and OO-Fe homodimeric proteins about 0.5
OD (figure 4.13).The rest of clones were frozen down and kept as a backupin liquid
nitrogen.
A large quantity of CO-Fce is required for experiments so, one vial of the
frozen final clone (IIG4) was thawed, spun and then resuspended in small flask in
culture medium with 10% FCS for 24 hours at 37 °C and 5% CO2. When they
become confluent, then transferred into medium sized flask for another 24 hours,
then split the cells into four medium sized flasks with a lower concentration of FCS
of 5% to be ready for the next step. Each flask was expandedinto five (15 cm dishes)
to get finally 20 X 15cm dishes which were cultured in 2% low IgG serum (Hyclone)
because the normal serum contain about 5.0 mg/ml of IgG which will interfere with
protein A agarose beads during purification. Protein A agarose beads were used to
concentrate and purify 500ml of supernatant of the stably transfected CHOcell line
cultured for 1 week in 2% low IgG.It was important to adjust the pH of the medium
to pH8prior to the addition of the beads to improve the binding. CO-Fc waskept in
contact with the beads onthe rotator for 2 to 24 hours at 4°C to increase the chance
of the binding of CO-Fcto the beads (figure 4.14a). In figure 4.14b,serial fractions
of the elution of the protein A agarose column were dotted and dried on filter
paper, and then stained with Coomassie stain for few minutes, followed by several
washes with destain solution. High concentration of the protein was shown by most
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of the dots. All factions with detectable proteins were included together and
concentrated by spin columnto Iml.
Because CO-Fc heterodimeric protein could not be isolated free from IgG in
the culture medium beside the CC-Fe and OO-Fc homodimeric proteins, it was
necessary to devise a method to be able to compare the quantity of CO-Fc in
different samples. Firstly, the linear range of the ELISA wasestablished. (figure
4.15a). In figure 4.15b, an arbitrary unit was introduced from a normalised curve for
ELISA assay at the linear range for CO-Fc heterodimeric protein, OO-Fc
homodimeric protein and CC-Fc homodimeric proteins. It was decided that CO-Fc,
OO-Fc and CC-Fc that gave absorption of 0.5 at 450nm was | AU/ml. Hence,if a
1:1000 dilution gave an OD of0.6 then the neat solution would have a concentration
of 1200 A.U. (1.2 A.U. would give an OD of 0.6). Using A.U. for the concentration
of CC-Fe and OO-Fe would also mean that the concentration of both could be
comparedin different samples.
The next step was the purification of the CO-Fc heterodimeric chimeric
recombinant protein from either OO-Fc or CC-Fe homodimeric proteins. This was
necessary for binding experiments but not for outgrowth assay experiments where C-
Fe and O-Fc do not interfere in these experiments. Both epitope V5 and myctags
mayplaya role in the process of purification; anti-myc column was assembled to be
used in purification of CO-Fe heterodimeric protein of the contamination of CC-Fc
homodimeric protein (figure 4.16).
In figure 4.17a, an anti-myc affinity column was used to purify the CO-Fc and
OO-Fe away from the CC-Fc.In the elution (1ml), CO-Fc, OO-Fe and CC-Fe were
assayed in different dilutions. All readings were in the linear range. The flow through
of the column was analysed for CO-Fc, OO-Fe and CC-Fc in different dilutions and
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indicated that the column eliminates most of the CC-Fe but there was unexpected
loss of CO-Fe (figure4.17b).
Anti-V5 affinity column was used also as a secondtrial to purify the CO-Fc
from OO-Fc(figure 4.18). In figure 4.19a, ELISA assayed CO-Fc, OO-Fe and CC-Fe
in different dilutions. The flow through of the anti-V5 affinity column was analysed
and indicated the same problem as the antimyc column (figure4.19b). In figure 4.20,
a table summarises the data of the elution and flow through for both column in
arbitrary unit (AU/ml) which revealed that both columns purified CO-Fc. However, a
high level of contamination remained in the elution of each column.
The concentration of CO-Fc is not known,so to ensure that a comparable amount of
CO-Fc wasusedto coat coverslips in outgrowth assay experiments, Western blotting
was used to compare the concentration of the total Fe recombinant protein in the
mixture of CO-Fc, OO-Fe and CC-Fc, in addition to the bovine IgG. C-Fe and O-Fc
single recombinantproteins were run alongside the CO-Fc. The concentration of the
total Fe protein was estimated from previous experience of production of
recombinant protein by adherent cells similar to CHO cells. The Western blot
indicated that the band for total amount of Fc recombinant protein was similar to
either band for C-Fc or O-Fc, whereas CO-Fcis the higher concentration in the total
Fe recombinant proteins based on ELISA assay (figure 4.21a). The western blot was
scanned using Image J software and the density profile was printed onto paper. The
appropriate peaks were cut out and weighed using an analytical balance. In figure
4.21b, the graph showsthe relationship betweenthe dilutions of chimeric protein and
the weight of the peaks, generated by scanning each track with imageJ software.
Three samples gave relatively similar peaks confirming that a the CO-Fc
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concentration was comparable to the C-Fe and O-Fc concentrations used in previous
neurite outgrowth experiments.
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DISCUSSION:
It proved to be difficult to produce a doubly transfected myelomacell line.
The transfection efficiency was low compared with CHO cells and even the Amaxa
nucleofector (electroporation) failed to give better than ExGene500
(polyethylinamine) transfection efficiency as judged by the number of GFP
expressing cells after 48hours. Strangely, the double transfected cells also exhibited
instability such that subcloned colonies showed increasingly unbalanced expression
of the recombinantproteins. Finally it was decided to use CHO cells to generate the
doubly transfected cell line. CHO cells were transfected with both V5 epitope tagged
CEPU-Fe in pcDNA6 and myc epitope tagged OBCAM-Fc in pBudCE4.1. Both
Zeocin and Blasticidin antibiotics were used to screen the cells transfected with both
pBudCE4.1 and pcDNA6. 60% of the cells died with Zeocin at concentration
200ug/ml and 5 wg /mlof Blasticidin in the first three days, and the rest of the cells
died after one week. During a stable cell line generation, high concentration of
antibiotics will slow the growth of the transfected cells. Although some non-
transfected cells may continue to grow, they will be eliminated during subcloning
process.
The level of expression of CC-Fce and OO-Fc washigher in the CO-Fc stably
transfected cells compared to the transiently co-transfection. The best clone (G9) of
the first round subclone secreted much higher CC-Fc and OO-Fc than CO-Fc. This
might be due to presence of more than onecell in one well of subcloning plate that
are singly transfected and produced only either CC-Fe or OO-Fc homodimers.
Therefore, a second round of subcloning wascarried out, and successfully, the final
clone (G4) of the second roundsecreted higher CO-Fe than CC-Fe and OO-Fc.
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The recombinant chimeric protein was expanded into 20X 150 cm dishesfor a
week instead of using miniperm because the transfected CHO cell line is an adherent
cell type and the outcome of the miniperm bioreactor was not promising when used
previously by our group for adherentcelllines.
The concentration for CC-Fe is (900AU/ml) which less than CO-Fc
(1300AU/ml) and OO-Fc (500) is the least. The shallower gradient may be a
reflection of CC-Fe and OO-Fc assay being less efficient than CO-Fc because the
same antibody is used for both capture and detection and the capture antibody might
occupy both epitope tags. The difference between CC-Fc and OO-Fc maybe due to
efficiency of HRP labelling of the secondary antibody.
Anti-myc and anti-V5 coupled beads columns were used to attempt to purify
the CO-Fc heterodimerprotein from the CC-Fe and OO-Fc homodimers. The idea of
use ofthe affinity columns wasto preserve the CO-Fe with one of homodimers and
then discard the other homodimer according to which column wasused. Then either
anti-myc or anti-V5 antibodies can be used to detect the CO-Fc protein alongside the
flow through of the columnswill be used as negative control. For example, anti-myc
antibody can be used to detect the CO-Fc isolated using the anti-V5 column where
the expected OO-Fc in the flow through can be used as negative control. However,
the presence of the same tags on the homodimers either CC-Fe or OO-Fe may
increased the chanceof their binding to the columnsagainst the chance of binding of
CO-Fc heterodimer which has two different tags and this may haveled to a loss of
CO-Fe through both columns. For example, in the case of the myc column, the
chance of binding of OO-Fc with two myc tags might be greater than the chance of
CO-Fc, which has one myctag.
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The reason for the CC-Fc appearing in the elution from the anti myc column
is unclear, it could be due binding of CC-Fce to OO-Fce via head groups. However,
there was less OO-Fe than CC-Fc (Fig 4.13). The same reason may account for OO-
Fe appearing in elution of myc column. As conclusion, myc and V5 columns were
not useful as CO-Fe was lost from both and neither efficiently removed the
contaminant expected.
The recombinantprotein mixture used for neurite outgrowth assays was not a
problem as CC-Fe and OO-Fc have been shown to have no effect. For the cell
binding experiments the myc antibody could be used as OO-Fc waspreviously
shown to have minimal binding to neurons.
In the next chapters, anti-myc antibody will be used to detect CO-Fc
heterodimeric chimeric recombinant protein at neat concentration to investigate its
binding to neurons, frozen sections and IgLON transfected cell lines with
recombinant proteins produced from single transient transfections as negative
control. Anti myc will not detect CC-Fe hence CC-Fc will not interfere in these
experiments.
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Figure 4.1: Blasticidinand ZeocinKilling Curves
A) The killing curve for Zeocin antibiotic with Wild type CHO cells or at 50%
confluency with serial dilutions; 50ug/ml, 100ug/ml, 200ug/ml, 400ug/ml, 600ug/ml,
800ug/mlandfinally Img/ml after 3 days of incubation at 37°C and 5% CO2, The
number of dead cells increased gradually with the increasing concentration of the
antibiotic. Most of the cells died between 200ug/ml to 400ug/ml while the entire cell
population died at 600ug/ml.
B) The killing curve for Blasticidin antibiotic with Wild type CHO cells at 50%
confluency with serial dilutions; 2ug/ml, S5ug/ml and I0ug/ml after 3 days of
incubation at 37°C and 5% CO2 10% of the cells had died at 2ug/ml. At 5ug/ml, most
of cell had died and 10ug/ml was aggressive on the cells since all died onthefirst
day.60 % of cells died in the first three days with 200ug/ml Zeocin and 5ug/ml and
100% cell died after 8-10 days.
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Figure 4.2: Dot blot for myelomacell line subclones from 96 well plates:
The supernatants of different clones of CO-Fc myeloma cell line dotted on a
nitrocellulose membrane. They were stained with both mouse antiV5 and antimyc
antibodies (Invitrogen) (1:2000). Anti-mouse HRP was used as secondary antibody
(Dako) (1:2000). The red circles represent the positive control, which is CO-Fc
transient transfection while the yellow circles are negative control.
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 Figure 4.3: Dot blot for CO-Fc myelomacell line from 24 well plate
The supernatants of different clones of CO-Fc myeloma cell line dotted on a
nitrocellulose membrane. They were stained with both mouse antiV5 and antimyc
antibodies (Invitrogen)(1:2000). Anti-mouse HRP was used as the secondary
antibody (Dako)(1:2000). The red circles represent the positive control which are
CO-Fctransient transfection while the yellow circles are negative control. There are
some clones that express both myc and V5 where other clones express only myc
while no or low expression of V5 which means un equal expression of both CEPU-
Fc-V5 and OBCAM-Fc-myc.
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Figure 4.4: ELISA Assay for best clones of CO-Fc myelomacellline:
ELISA assay for 10 x concentrated of 10 ml of supernatants of the three clones (IF9-
IIC6-II H5) were assayed by using anti-myc or anti-V5 antibodies as primary
antibody (Invitrogen) (1:300). Anti-myc or anti-V5 —HRP labelled antibodies
(Invitrogen) (1:500) were used as secondary antibody. The concentration of CO-Fc
heterodimerfrom three clones was low (0.1-0.2 OD) while the concentration of OO-
Fe and CC-Fc homodimersare higher than CO-Fc butstill low.
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Figure 4.5: CO-Fc Stable transfection of CHO cellline
A diagram describes the steps of the CO-Fc stable transfected CHO cell line
CEPUFc (pcDNA6) (Iug/ul) and OBCAM-Fc (pBudCE4.1) (Iug/ul) using
ExGEN500 (Fermentas). The next step was screening for pcDNA6 whichis resistant
to Blasticidin (5ug/ml), and pBudCE4.1 which is resistant to Zeocin (200ug/ml).
Finally, CO-Fc stably transfected clone after a numberofsubclones wereselected.
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 Figure 4.6: CO-Fc transfected selected clone
The first photograph is a phase picture for a selected clone in 96 well plate, the
second oneis a fluorescent picture for the same clone with GFP fluorescent protein
which was used to check the transfection with OBCAM-Fc in pBudCE4.1 (scale
bar50um).
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Figure 4.7: final clone (G9)of the first round of subcloning
A graph shows an ELISA assay for CO-Fc using anti-myc antibody as capture
antibody and anti-V5-HRP labelled antibody as detection antibody.CO-Fc
concentration (blue bar) in the medium was about 0.35 OD. Anti-myc and anti-myc-
HRPlabelled antibodies were used for detection of OO-Fc. OO-Fc concentration
(red) was about 0.5 OD. For CC-Fc detection, anti-V5 and anti-V5-HRP labelled
were used (green) about 0.8 OD. The ratio is two for CC-Fc to one for CO-Fc and
OO-Fc. It was expected to be two for CO-Fc heterodimer and one for each
homodimer. (n=3)(SEM= CO-Fc 0.0064, OO-Fc 0.025, CC-Fc 0.038).
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Figure 4.8: Dot Blot for CO-Fe subclones with antimyc and antiV5
antibodies
Dotblotsfor the selected coloniesfrom 96 well plate. Thefirst blot was stained with
mouse anti-myc antibody (1:2000) (Invitrogen)to test the generation of OBCAM-Fc-
myc-His6 protein, and the second one was stained with mouse anti-V5 antibody
(1:2000) for CEPU-Fc-V5-His6. Secondary anti-mouse HRP labelled (1:2000)
(Dako) was used. The yellow circles represent colonies with equal expression of
CEPU-Fc-V5-His6 and OBCAM-Fc-myc-His6, while red circles represent unequal
expression ofboth chains. Negative controls were encircled by blackcircles.
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Figure 4.9: ELISAassaysfor the selected colonies from 96 well
plates
A graph shows an ELISA assayfor a numberofselected colonies from 96 well plates
using anti-myc antibody (Img/ml) (1:300)asfirst capture layerfor OBCAM-Fc-myc-
His6 chain and anti-V5 HRP labelled antibody (1:500) to detect the CEPU-Fc-V5-
His6 chain to testfor CO-Fc heterodimer recombinant protein secreting colonies. An
ELISA micro plate reader was used at 450mm wavelength. The red bars represent
the colonies that produced the highest concentration of CO-Fc; IDI, ID6, IE6 and
finally IE10.
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Figure 4.10: ELISAassayfor the selected colonies from 24 well
plates for CO-Fc heterodimer, OO-Fc homodimer and CC-Fc
homodimer
A graph for ELISA assay showsthe ratio of the secreted CO-Fc heterdimer (blue)
using anti-myc and anti-VSHRPantibodies to the OO-Fc (red) using anti-myc and
anti-mycHRP antibodies and CC-Fc (green) using anti-V5 and anti-VSHRP
antibodies. ID1, ID6, IH3, IIG4, IIG7, ITH9 and ITH11 clones(red regtangles) were
selected that produce CO-Fc more than OO-Fc and CC-Fcto be transferred to a 6
well plate.
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Figure 4.11: ELISAassayfor the selected colonies in 6 well plate
A graph shows an ELISA assay for the selected clones. The CO-Fc concentration
varies from one clone to another. IDI, ID6, 1H3, IIG4, IIG7, ITH9 and IIHII were
transferred to smallflasks because they secret more CO-Fc heterodimer than OO-Fc
or CC-Fc homodimers.
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Figure 4.12: ELISAassayfor the selected subclones in small sized
flasks
A graph shows an ELISA assay for the selected clones in small flask. The best clone
is 1IG4 that produce twice as much CO-Fc (blue) (0.9 OD) as the OO-Fc (red) or
CC-Fc (green) (0.5OD).The other clones still produce higher concentration of CO-
Fc but the concentration of the homodimersis still more than IIG4. (n=3)(SD= ID6
0.0674, 0.0160, 0.057-IH3 0.071501, 0.03245, 0.01305-IIG4 0.02700, 0.0308,
0.04087- IIG7 0.0449, 0.0485, 0.03178- ITH9 0.03439, 0.0094, 0.0087-ITH11 0.0334,
0.0269, 0.09603 for CO-Fc, OO-Fc and CC-Fcrespectively.
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Figure 4.13: ELISAassay for the Final clone of CO-Fc
A graph shows an ELISA assay for the final clone which is IIG4 after many
subclones. The ratio of the CO-Fc concentration is double (1.0 OD) the
concentration of OO-Fc or CC-Fc homodimers (0.5) in large flask which prove the
stability of the cell line. (n=3) (SEM= CO-Fc 0.024, OO-Fc 0.010, CC-Fc 0.024)
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Figure 4.14: Purification of CO-Fc with Protein A agarose beads
column
(A) Thefirst diagram describes the structure of the protein A agarose beads (Sigma)
column. The CO-Fc heterodimeric protein interacts with beads with the human Fc
tail of the complex.
(B) The second picture shows a Coomassie stain for serialfractions of the elution of
the protein A beads column (100ug/ml) on a filter paper. The concentration of the
protein gradually decreased until it disappearsin the last twofractions.
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Figure 4.15: ELISAassaysfor the elution of Protein A agarose beads
column
A graph shows a normalised curve for ELISA assay for the elution of protein A beads
column. The concentration of CO-Fc heterodimeric recombinant protein is still higher than
the concentration of the OO-Fc or the CC-Fc homodimers. The linear range is between 0.001
to 0.003 dilutions.
An arbitrary unit (AU/ml)was introduced to measure the concentration of the recombinant
protein from the ELISA curve at the linear range, 0.5 OD equal 1 AU/ml. CO-Fc is about
1300AU/ml CO-Fc, OO-Fc is S00AU/ml and CC-Fc is 9OOAU/ml.
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Figure 4.16: an illustration describes the principle of an anti-myc
column
This diagram describes the purification of CO-Fc by anti-myc column which is
composed of myc coupled beads. The myc tags of both CO-Fc and OO-Fcwill bind
to the beads and be located in the elution of the column, while the CC-Fc will not
bind to myc beads andwillbe in theflow through of the column.
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Figure 4.17: Purification of CO-Fc with anti-myc column
A) A graph show the elution of anti-myc affinity column, CO-Fc (blue) at 0.01 and
0.002 and 0.001, OO-Fc (red) at 0.01 and 0.02 and CC-Fc (green) at 0.1 dilutions.
B) A graph showstheflow through of anti-myc column CO-Fc(blue) at 0.01, OO-Fc
(red) 0.1, CC-Fc (green) at 0.01, .0.02 and .001dilutions.
The arbitrary unitsfor both elution andflow throughwill be in table in figure 4.15.
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Figure 4.18: an illustration describes the principle of an anti-V5
column
This diagram describes the purification of CO-Fc by anti-V5 column which is
composedof V5 coupled beads. The myc tags of both CO-Fc and CC-Fc will bind to
the beads in the elution of the column, while the OO-Fc will not bind to myc beads
andwill beflow through of the column.
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Figure 4.19: Purification of CO-Fc by antiV5 affinity column
A) A graph showsthe elution of anti-V5 affinity column, CO-Fc (blue) at 0.01, 0.002
and 0.001 dilutions. OO-Fc (red) at 0.1, 0.02 and 0.01 dilutions and CC-Fc (green)
at 0.001dilution.
B) A graph showsthe flow through of the anti-V5 affinity column, CO-Fc (blue) at
0.1 dilution, OO-Fc (red) at 0.02, 0.01 and 0.002 dilutions, CC-Fc (green) at 0.1
dilution. The arbitrary units for both elution and flow through will be in table in
figure 4.17.
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A) Antimyc column
Protein Elution Flow through
CO-Fc 120AU/ml 20A U/ml
OO-Fc 40AU/ml 4AU/ml
CC-Fc 160AU/nl 100A U/ml   
B) Anti-V5 column
Protein Elution Flow through
CO-Fc 216AU/ml 22AU/ml
OO-Fc 83AU/ml SOAU/ml
CC-Fc 1340AU/ml 16AU/ml   
Table 4.20: table listing the concentration of the elution and flow
through for anti-myc and anti-V5 columns in AU/ml
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Figure 4.21: Western blot to estimate the concentration of CO-Fc
heterodimeric protein
A)
B)
A western blot shows bands for CEPU-Fc (1st lane), OBCAM-Fc (2nd lane) single
recombinant protein (200ng/ml) and CO-Fc heterodimeric protein (1:10). The CO-Fc
concentration that was loadedonto the gel was estimatedfrom previous experience
of production of recombinant protein by adherentcell line. The blot stained by
primary rabbit anti-human Fc antibody (1:1000) and secondary anti-rabbit HRP-
labelled (1:2000). West Pico (Pierce) was used and exposure time was 1 minute. The
blot revealed similar concentration of C-Fc, O-Fc and CO-Fc recombinantproteinsin
three lanes.
A graph shows the relation between dilution factor of each band of the three
proteins and their weight when they scanned with image J software. The
concentration of all three chimeric proteins used for the outgrowth assays were
relatively similar.
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Chapter Five
The activity of CO-Fc heterodimeric
recombinant protein
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INTRODUCTION:
In the previous chapter, CO-Fe heterodimeric chimeric recombinant protein
was generated bystable transfection of wild type CHOcell line with both pcDNA-6-
CEPU-1-Fc-V5 and pBudCE4.1-OBCAM-Fc-myc.In this chapter, the activity of the
CO-Fc heterodimeric protein will be tested on the outgrowth of the neurons in
comparison with the effect of the CO double transfected CHOcell line.
Previously, GP55 protein which is a mixture of IgLONsinhibited the neurite
outgrowth from DRG and forebrain neurons. This suggested that GP55 contained
heterodimeric complexes (DigLONs), since there was no or minimal effect on the
neurite outgrowth with either single CEPU-1 or OBCAM (Clarke and Moss, 1994,
1997) (McNameeetal., 2002). In addition, the CEPU-1-OBCAM (CO) double
transfected CHOcell line inhibited the initiation of the neurite outgrowth from a
subpopulation of cerebellar granule cells (CGC) (Reed et al., 2004). These data
suggested that IgLONs become active when present as a heterodimer complex
(DigLON). There is indirect evidence to suggest that CO, CL and LO DigLONs
could be formed (Reed et al., 2004). A DigLON is a combination between two
different members of the group. There are six possible combinations of IgLONs and
hence they may besix different DigLONs (Reedetal., 2004).
Recently it has been shownthatinitiation of neurites from E7/E8 forebrain
neurons were inhibited when they were grown on double transfected CO and CL
CHOcell line (Christine McNamee PhD Thesis University of Liverpool 2008), while
no inhibition with single IgLONs wasobserved.
The inhibition of the initiation of neurites could have occurred due to
interaction between the DigLON expressed on transfected cell lines and IgLONsor
DigLONthat are expressed onthe surface of the neurons. However, this requires that
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the IgLONsshould be able to signal to the neuronal cytoskeleton and since they do
not have a cytoplasmic domain, the mechanism in this case is unclear.
A secondpossibility is that the receptor could be a transmembrane receptor
that has a cytoplasmic domain that can initiate the signaling pathway. The third
possibility is that DigLON bind to a complex formed by transmembrane receptor
beside IgLON(figure 5.1).
To investigate whether IgLONs form part of the receptor, the response of
neurons to DigLONswill be tested with and without surface IgLONs. IgLONs can
be removed from the surface of the neurons by treatment of the neurons with PI-PLC
that cleave the GPI anchor. This is an advantage of the CO-Fc recombinantprotein as
tool since this experimentis not possible with CO-CHOtransfected cell line (Marget
al., 1999; McNameeetal., 2002).
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MATERIALS AND METHODS:
PIPLC Treatment: Phosphatidy] inositol-specific phospholipase C
(Molecular Probe)
IgLONsare cell adhesion molecules attached to the cell membrane by GPI
anchoredprotein.
PI-PLC was used to cleave IgLONs from the surface of the neurons at GPI
anchorsite while keep the neuronsalive.
E8 chick forebrain dissociated neurons were incubated in forebrain culture
medium that contain PI-PLC (1.0 U/ml) for 1 hour at 37°C and 5%COz. Then, the
treated neurons were resuspended in forebrain culture medium that contains
(0.1U/ml) PI-PLC.Instantly, the treated neurons were counted and then plated in a
24 well plate that has precoated cover slips with Poly-Lysine, protein A (Sigma)
which is responsible for the orientation of IgLON heads and then coating standard
single chimeric proteins such as CEPU-Fc, OBCAM-Fc or CO-Fc heterodimeric
chimeric recombinant protein for neurite outgrowth assay experiments (Gil etal.,
1998).
126
RESULTS:
Neurite outgrowth assay experiments were used to investigate the activity of
the CO-Fc heterodimeric recombinant protein. It was used as a substrate on
nitrocellulose coated coverslips alongside the standard chimeric protein CEPU-Fe or
OBCAM-F¢asnegative controls.
Thefirst experiment was on E8 forebrain neurons(figure 5.2), the graph shows
a normalised relation between the percentage of the neurite outgrowth with different
chimeric proteins CEPU-Fe (100ug/ml), OBCAM-Fc (100ug/ml) and CO-Fc
heterodimeric protein. The concentration of CO-Fc was 700AU/ml based on a
correlation between ELISA assay and western blotting. 50% of the neurons were
inhibited from extending their neurites due to the effect of CO-Fc heterodimeric
chimeric protein while minimal inhibition occurred with CEPU-Fc and noinhibition
with OBCAM-Fc standard chimeric proteins. The forebrain neurons that extend
neurites with length double the diameter of the cell body were counted.In figure 5.3,
photographs represent the inhibition of outgrowth assay experiment for forebrain
neurons at E8. Photographs showed that most of the neurons were able to initiate
their neurites with polyLysine, CEPU-Fc or OBCAM-Fc single chimeric proteins
while on CO-Fe a subset of neurons were inhibited by CO-Fc heterodimeric protein.
In figures 5.4, E10 dorsal root ganglion neurons were cultured on coverslips
that were coated with CEPU-Fc (100ug/ml), OBCAM-Fe (100ug/ml) or CO-Fe
(700AU/ml) alongside a positive control with laminin. The first bar on the graph
represents the percentage of neurite outgrowth on laminin only, which was about 90
%. Neither CEPU-Fc nor OBCAM-Fc inhibited the neurite outgrowth which was
almost similar to the normal outgrowth on laminin. No inhibition occurred when CO-
Fc used at the same concentration used with E8 forebrain (700 AU/ml). This result
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was similarly to that observed previously where E10 DRG neurons extended axons
on CO-CHO cells. However, significant inhibition occurred with the 4xfold
concentration of CO-Fc heterodimeric protein (2700AU/ml), 75% of the neurons
were not able to initiate their neurites (figure 5.5). The photographs showed that
neurite outgrowth occurred with laminin, C-Fe or OB-Fe while CO-Fe (2700AU/ml)
inhibited the neurite outgrowth (figure5.6).
In figure 5.7, the lower concentration of CO-Fe (700AU/ml) failed to inhibit
the neurite outgrowth from E10 sympathetic neurons, while 4 fold higher
concentration of CO-Fc heterodimeric protein (2700AU/ml) inhibited the outgrowth
of E10 sympathetic neurons, approximately, 80% of the neurons were inhibited to
extend their neurites (figure 5.8). In both cases CEPU-Fc or OBCAM-Fc were
unable to prevent the neurons from extending their neurites which was similar to
those neurons grown onthe laminin control. CO-Fe as seen in photograph (CO-Fc)
inhibited the outgrowth from the neurons whereas no inhibition occurred with
laminin, C-Fe or OB-Fc photographs(figure5.9). All experiments were carried out in
triplicate. The number of counted neurons was about 300 in each experiment. Prism
software was used to produce these graphs.
Finally, to investigate whether IgLONsare involved in the formation of the
putative receptor complex, E8 chick forebrain neurons were treated with PI-PLC.PI-
PLCtreatmentis used to release the GPI anchored proteins including Ig_LONs from
the surface of the neurons.
In figure 5.10, fluorescent photographs showed that IgLONs are expressed on the
cell bodies, axons and dendrites of E8 chick forebrain neurons. The staining of the
PI-PLC treated E8 forebrain neurons with IgLONs antisera (anti-CEPU-1, anti-
OBCAMandanti-LAMP)revealed that no IgLONsstill expressed on the surface of
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the neurons after the treatment with PI-PLC (figure5.11). In the outgrowth assay
experiment, there was a significant difference between PI-PLC treated and untreated
forebrain outgrowth with CO-Fc, while no significant difference in treated and
untreated forebrain neurite outgrowth with C-Fe and O-Fc standard chimeric protein
was observed (figure5.12). This suggests that GPI-anchored protein including
IgLONs/DigLONs mayhavea role in the formation of the putative receptor for CO-
Fc heterodimeric protein, howeverfurther investigations are required to support this
evidence.
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DISCUSSION:
The initiation of the neurite outgrowth from forebrain, DRG or sympathetic
neurons was inhibited by the action of CO-Fc heterodimeric chimeric recombinant
protein while no inhibition occurred with single CEPU-Fce or OBCAM-Fc or mixed
together. This data supported the evidence that GPSS may contain heterodimeric
complexes which inhibit the outgrowth from DRGneurons (Clarke and Moss, 1994).
Protein A was used in these experiments to orient the protein to allow the IgLONs
heads of the CO-Fce complex to contact with the neurons. The fact that CO-Fc
heterodimeric protein preparation was contaminated with CC-Fe and OO-Fc
homdimeric protein was not a problem in this experiment, since no inhibition
occurred with CEPU-Fe or OBCAM-Fc recombinant proteins controls. The
concentration of the CO-Fe was comparable to that used for CEPU-Fc and OBCAM-
Fc based on the correlation between the ELISA assay and the western blot results for
CEPU-Fc, OBCAM-Fc and CO-Fc using anti-human Fe antibody. Furthermore, no
inhibition of the initiation of the neurite outgrowth of forebrain neurons occurred
when both CEPU-Fe and OBCAM-Fc single recombinant proteins were mixed
together (McNameeetal., 2002) (Michael Lyons).
The inhibition occurring with CO-Fc is similar to that observed with double
transfected (CO) CHOcell line in case of forebrain neurons (Christine McNamee
PhD Thesis University of Liverpool 2008). On other hand, CO-CHO and CO-Fc
were unable to inhibit the neurite outgrowth of DRG or sympathetic neurons.
However, significant inhibition occurred on both DRG and sympathetic neurite
outgrowth when 4xfold concentration of CO-Fe was used. Surprisingly, the 4x fold
concentration difference goes from 0 to 75% inhibition whilst only 50% forebrain
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neurons were inhibited. This might be due to heterogeneity of forebrain neurons
versus DRG and sympathetic neurons.
IgLONsare expressed in different part of the forebrain, CEPU-1 is expressed
in the ventricular surface of the anterior part of E8 forebrain section, while OBCAM
is expressed in posterior part of E6 forebrain section. Furthermore, E8 forebrain is a
site for co-expression of IgLONs, LAMP-CEPU-1 are co-expressed posteriorly,
where the anterior part of the forebrain showed a co-expression of LAMP and
OBCAM (Sahar Youssef PhD thesis Liverpool University 2007). In addition,
IgLONsare expressed by both dorsal root ganglion and sympathetic chain neurons
(Gil et al., 1998; McNameeetal., 2002). This evidence suggests that CO-Fc may
interact with IgLONs on the surface of forebrain, DRG and sympathetic chain
neurons. There is expression of IgLONsin E7 chick spinal cord, LAMP, OBCAM
and CEPU-1 are co expressed in dorsal roots (Sahar Youssef PhD thesis Liverpool
University 2007). IgLONs may promote the preganglionic neurons to innervate the
sympathetic chain through trans homophilic or heterophilic interactions.
In vivo, CEPU-1 is expressed early during the development of neurons; the
intensity of staining of CEPU-1 varies from faint in the anterior ectoderm and
mesenchymeregion of chick embryo to moreintensein the neural plate (Jungbluthet
al., 2001; Kimuraet al., 2001). With development, a broad band of CEPU-1 mRNA
expression is situated to the area of forebrain, midbrain and anterior hindbrain.
However, it became morelocalised at the isthmus or midbrain-hindbrain boundaryat
(E2) embryonic day (Jungbluth et al., 2001). During migration of the neurons,
CEPU-1 is expressed in primary sensory and motorregionsofthe rat brain, mainly,
restricted to postmitotic neuronsthat increase in the rat forebrain from the age of E15
(Gil et al., 2002; Struyket al., 1995). On other hand, OBCAM is expressed later than
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CEPU-1 mainly in the cerebral cortical plate and hippocampusregions of the brain
(Struyk et al., 1995). In addition, in situ hybridization data showed that CEPU-1 and
OBCAMexpressed in the notochord and floor plate in chick embryo at E3 (Sahar
Youssef PhD thesis Liverpool University 2007).
CO-Fc heterodimeric protein may bindto the putative receptor complex on the
surface of the neurons to inhibit the initiation of the neurite outgrowth. IgLONs
could be part of this complex. Because they don’t have cytoplasmic domain, a
transmembranereceptor may be required to form a complex with IgLONto signal to
the cytoskeleton (figure5.10). Removal of the GPI anchored protein including
IgLONs from the surface of the neurons suggested that IgLONs may havea role in
the formation of a putative receptor complex for CO-Fe heterodimeric chimeric
recombinant protein. Hence CO-Fe requires the interaction with GPI anchored
proteins on the surface of the neuronsto inhibit their neurite outgrowth.
In the next chapter, the nature of the putative receptor complex for CO-Fc
heterodimeric protein will be investigated using immunofluorescence studies
investigating its interaction with E8 forebrain, E10 dorsal root ganglion and
sympathetic neurons. In addition, the interaction E18 chick retina frozen sections
which is a commonsite for expression of IgLONswill also be investigated. Analysis
of the binding of CO-Fe to IgLONtransfected cell lines will provide insight into the
IgLONsspecificity and which IgLONs maybe are involved in the receptor complex.
Finally, binding experiments to neurons treated with PILPC to remove the GPI
anchored proteins will confirm the loss of binding of CO-Fc to the surface of the
neuron in absence of IgLONs.
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Figure 5.1: Diagram to describe the proposed options for the nature
of the putative receptors for CO-Fc heterodimeric protein
A) The first option is that CO-Fc binds a transmembrane receptor with a
cytoplasmic domainthatinitiates the signalling pathway without IgLONs.
B) The second option is that CO-Fc binds to both IgLON and transmembrane
receptor that can signal through to the cytoskeleton.
C) The third option is that CO-Fc binds to IgLON alone, however the
mechanism of signaling in this case in unknown.
D) The last option that CO-Fc binds to DigLON and the mechanism ofsignalling
is again unknown.
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Figure 5.2: CO-Fc inhibits neurites outgrowth from E8 Forebrain
neuron
E8 Forebrain neurons were cultured on coated cover slips with L- polylysine
(10ug/ml), protein A (100ug/ml) and chimeric proteins OB-Fc (100ug/ml) C-Fc
(100ug/ml) and CO-Fc heterodimeric protein (700AU/ml). It was normalised against
the higher control (OB-Fc) to 100%. There is a significant difference between CO-
Fc, C-Fc and OB-F c (p value<0.05*) while no significant difference between C-Fc
and OB-Fc (p value>0.05). (n=3) (SEM= OB-Fc0, C-Fc 5.774, CO-Fc 1.667).
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Figure 5.3: E8 Forebrain neurite outgrowth assay
Photomicrographs show that forebrain neurons were cultured on coated coverslips
with nitrocellulose, polylysine, protein A (100ug/ml) and standard IgLON chimeric
protein; OB-Fc) or C-Fc(C) as well as CO-Fc heterodimeric chimeric protein. CO-
Fc inhibits the initiation of their neurites when compared with C-Fc, OB-Fc and PL
(scale bar 50um). 300 cells were counted doubleblindin three separate microscopic
fields.
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Figure 5.4: CO-Fc does not inhibits neurite outgrowth from E10
dorsal root ganglion neurons (DRG)at low concentration
E10 dorsal root ganglion neurons were cultured on coated cover slips with
nitrocellulose, Laminin, protein A (l0Oug/ml) and chimeric protein C-Fc
(100ug/ml), OB-Fc (100ug/ml) and CO-Fc heterodimeric protein (700AU/ml). The
1"barisfor neuron grown on laminin only, the 2" barfor the neurons grown on C-
Fc substrate, the 3”for neurons grown on OB-Fc substrate. The last barfor neurons
were grown on CO-Fc substrate, there was no inhibition of neurite outgrowth. No
significant difference between CO-Fc, OB-Fc, C-Fc and LN (p value >0.05).(n=3)
(SEM= LN 0.882, C-Fc= 1.202, O-Fc 0.667, CO-Fc 4.177).
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Figure 5.5: CO-Fc inhibits neurite outgrowth from Dorsalroot
ganglion neurons (DRG)at high concentration
E10 dorsal root ganglion neurons were cultured on coated cover slips with
nitrocellulose, Laminin, protein A (l0Oug/ml) and chimeric protein C-Fc
(100ug/ml), OB-Fc (100ug/ml) and CO-Fc heterodimeric protein (2700AU/ml). The
1"bar is for neuron grown on laminin only; the growth is about 90%, the 2"for the
neurons grown on C-Fc substrate, the 3” for neurons grown on OB-Fc substrate.
The last bar is for neurons were grown on CO-Fc substrate, there was about 75%
inhibition of neurite outgrowth. There is a significant difference between CO-Fc and
O-Fc, C-Fc and LN (p value<0.01**), while no significantdifference between O-Fc,
C-Fc and LN (p value>0.05.). (n=3) (SEM= LN 5.568, C-Fe 7.506, OB-Fc 11.015,
CO-Fc2.500).
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Figure 5.6: E10 DRG neuron outgrowth assay
Photographs show that the initiation of neurite outgrowth from E10 Dorsal root
ganglion neurons was inhibited due to the effect of CO-Fc heterodimeric
recombinant protein. The standard single chimeric IgLON chimeric proteins such as
C-Fc and OB-Fcfailed to inhibit while normal growth was observed with Laminin
(5Oum scale bar).
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Figure 5.7: CO-Fc does not inhibits neurite outgrowth from E10
Sympathetic neuronsat low concentration
E10 Sympathetic neurons were cultured on coated cover slips with nitrocellulose,
Laminin, protein A (10Qug/ml) and chimeric protein C-Fc (100ug/ml), OB-Fc
(100ug/ml) and CO-Fcheterodimeric protein (700AU/ml). The 1* bar is for neuron
grown on Laminin only; the growth is about 90%, the 2" barfor the neurons grown
on C-Fc substrate, the 3” for neurons grown on OB-Fc substrate. The last bar for
neurons were grown on CO-Fc substrate, there was no inhibition of neurite
outgrowth. No significant difference between CO-Fc, C-Fc, O-Fc and Laminin (p
value>0.05) (n=3) (SEM=LN 3.180, C-Fc 3.180, OB-Fc 0, CO-Fc 0).
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Figure 5.8: CO-Fc inhibits neurite outgrowth from E10 Sympathetic
neuronsat high concentration
E10 Sympathetic neurons were cultured on coated cover slips with nitrocellulose,
Laminin, protein A (100ug/ml) and chimeric protein C-Fc (100ug/ml), OB-Fc
(100ug/ml) and CO-Fc heterodimeric protein (2700AU/ml). The 1" bar is for
neurons grown on Laminin only; the growth is about 90%, the 2" bar for the
neurons grown on C-Fc substrate, the 3” for neurons grown on OB-Fc substrate.
The last bar for neurons were grown on CO-Fc substrate, there was about 80%
inhibition of neurite. There is a significant difference between CO-Fc, O-Fc, C-Fc
and LN (p value<0.01**), while no significant difference between O-Fc, C-Fc and
LN (p value>0.05).
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Figure 5.9:E10 Sympathetic neurons outgrowth assay
Sympathetic neurons (E10) were cultured on cover slips that were coated with
nitrocellulose, Laminin and IgLON chimeric proteins. The initiation of neurite
outgrowth was inhibited with CO-Fc heterodimeric recombinant protein (D). The
standard chimeric protein; C-Fc and OB-Fc did not inhibit (B and C) similar to
normal growth on Laminin (5Oum scale bar).
141
 
Figure 5.10: E8 Forebrain neuronsstained with IgLONantisera Pre
and Post PI-PLC treatment
A) E8 chick forebrain neuron were stained with IgLON antisera (1:50) and
secondary anti-rat Alexa Fluor 488 (1:200). IgLONs were expressed in cell
bodies, axons and dendrites.
B) After PI-PLC treatment of E8 forebrain neurons, no staining with IgLON
antisera was observed indicating that IgLONs were now undetectable on the
surface of the neurons(scale bar50um).
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Figure 5.11: Neurite outgrowth assay PIPLC treatment of PI-PLC
treated or untreated E8 Forebrain neurons with.
PI-PLC treated and untreated E8 forebrain neurons were cultured on a
nitrocellulose, polylysine (10ug/ml), protein A beads (100ug/ml) then coated with
either C-Fc, O-Fc (100 ug/ml) or CO-Fc (250AU/ml). The dark bars represent the
neurite outgrowth of untreated neurons, while the light bars represent the neurite
outgrowth ofneurons treated with PI-PLC.
There is a significant difference between CO-Fc (-) (untreated) and CO-Fc (+)
(treated (p<0.01*), while no significant difference was observed between O-Fc
(untreated and treated) or C-Fc (untreated andtreated) (p>0.05). This suggests that
GPI-anchored proteins have a role in the formation of the receptor complexfor CO-
Fe.
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Figure 5.12: Diagram to describe the proposed role of IgLONsin the
putative receptor complex for CO-Fc heterodimer
This is an illustration of an IgLON andassociated transmembrane receptorin lipid
raft in the cell membrane of neuron. The green structure represents a
transmembrane receptor with a cytoplasmic domain that could interact with an
IgLON to initiate the signalling pathway to the cytoskeleton. Results of PI-PLC
treatment suggested that IgLONs have a role in the formation of the putative
receptor, either with a transmembrane receptor as shown above or alone.
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Chapter Six
The interactions of CO-Fc
heterodimeric recombinant protein
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INTRODUCTION:
In this chapter, immunofluorescence studies will be used to show the
interaction of the CO-Fc heterodimeric chimeric recombinant protein with the
IgLONsand/or putative receptor complex on the surface of the cell membrane of
neurons,retina frozen sections or other IgLONtransfected cell lines.
IgLONsare cell adhesion molecules that are expressed in lipid rafts on the
surface of the neurons, and interact with each othereither in cis and/or in trans on the
plane ofthe cell membrane. Binding assay between IgLON-Fcandthe corresponding
IgLONtransfected cell lines have shown that CEPU-1, OBCAM and LAMPhave
either homophilic or heterophilic trans interactions (Brummendorf et al., 1997;
Lodgeet al., 2000; Reedet al., 2004). Ntm-Fe (CEPU-1) and OBCAM-Fc interacted
heterophilically with LAMP-CHOcells (Gil et al., 2002). No interaction occurred
with other Ig superfamily members tested so far such as, N-CAM andcontactin
recombinant-Fe protein. CO-Fc heterodimer complex can be used to investigate the
interaction between a putative DigLON, as it is formed of CEPU-1 head and
OBCAM-Fc head held together at the disulfide bridge of human IgG Fc tail and
specific Ig_LONs/DigLONs.
The CO-Fc complex could interact with IgLONs expressed on the surface of
the neurons. However, a transmembranereceptor may be required to form a receptor
complex in orderto signal to the cytoskeleton.
Anti-myc or anti-V5 antibodies can be used to detect the binding of the CO-Fe
complex, but because there is a mixture of CO-Fc heterodimeric, OO-Fe and CC-Fe
homodimeric recombinantproteins anti-myc was preferred to be used to detect CO-
Fe heterodimeric protein and not anti-V5 antibody. This is because previous work
showed that OBCAM binding is weak. While it revealed strong binding of CEPU-1.
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Based on the results in previous chapter, IgLONs may act as a part of the
putative receptor complex for the CO-Fc heterodimer protein. Therefore, immuno-
staining of neurons after PI-PLC treatment will be used to support the hypothesis of
role of IgLONsin formation of the receptor complex. Because the contaminating O-
Fc precludes the absolute certainty that the binding observed with the anti-myc
antibody is solely due to the CO-Fc, preliminary FRET experiments will be carried
outto try to confirm the specific binding of CO-Fc toretina.
The aim of FRET is to distinguish between the binding of CO-Fc
heterodimeric recombinant protein which is tagged with both myc and V5 epitope
tags, and either OO-Fc or CC-Fc homodimeric recombinant proteins which are
tagged by either two myc tags or two V5tags.
FRET can be used to specifically detect CO-Fc because of the proximity
between the myc and V5 tags. Direct labelling V5 with anti-V5 Alexa 488 and myc
with anti-myc Alexa 555 will result in FRET while single O-Fc or C-Fe will not.It is
important to confirm that a mixture of both O-Fe and C-Fc will not result in FRET.
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Material and Methods:
The materials that are required for FRET experiment are anti-V5 Alexa Fluor
488-labelled antibody as donor (ABDserotec) and anti-myc Alexa Fluor 555 labelled
as acceptor antibody (Millipore). There is an overlap between the emission of the
donor and the excitation of the acceptor (figure 6.11a). The Ro for both antibodies
fluorphors is 7nm at which about 50% ofthe energy that initiated by the excitation of
the donorwill be transferred to the adjacent fluorphor which will result in excitation
of the acceptor(figure6.11 b).
Transient transfection of CHO cells in 15cm dishes at cell count 1x10’ cell/ml
in 5% FCS with either pcDNA6-CEPU-Fc-V5 or pBudCE4.1-OBCAM-myc
endotoxin free plasmid (lug/ul) was carried out using TransIT (Mirus) transfection
reagent. The transfection efficiency was 60% and the medium waschanged to low
IgG medium which incubated for one week before collection of the supernatant of
each transfection. Concentration of the supernatants wascarried out by spin columns
(Sartorius) 10 times.
FRET between the two fluorphors was measured using FRET package on the
Leica (DM IRE2) confocal microscope. The fluorescence of the Alexa 488 (donor)
and the Alexa Fluor 555(acceptor) was measured, and then the acceptor was
bleached and the fluorescence of the donor was measured again. The increase in
donor fluorescence was a measure of the FRET that had occurredinitially.
In order to measure the ratio of energy transfer between two fluorphors for
CO-Fc, live staining of LAMP CHOcells wascarried out using anti-V5 Alexa Fluor
as donor and anti-myc Alexa Fluor 555 as acceptor with either CO-Fc or a mixture of
both CC-V5 and OO-myc recombinantproteins. Bleaching anti-myc Alexa Fluor 555
(acceptor) will allow the anti-V5 Alexa Fluor 488 (donor) to become brighter than
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before bleaching due to the 50% (if Ro=7nm) of energy that was going to be
transferred to the acceptor will be emitted by the donor due to close proximity
between VS5tag and myc tag of CO-Fc. In the case of CC-V5 and OO-myc mixture,
no FRET was expected to occur due to distance between two fluorphors. No change
will occur between the emission of the donor before and after the bleaching of the
acceptor(figure 6.12).
The following equation is required to measure the ratio of FRET:
Dpost — DpreFRET =—Dpost
RESULTS:
In this chapter, the interaction of CO-Fe heterodimeric chimeric recombinant
protein was investigated by immunofluorescencestudies with different types of cells
and tissues. CO-Fc heterodimeric recombinant is contaminated with OO-Fc and CC-
Fe homodimeric recombinant proteins. Anti-myc antibody was used to detect the
interaction of the CO-Fc; however, OO-Fe will be detected as well due to the
presence of the epitope myc tag in both proteins. It was important to perform control
experiments with OO-Fc alongside the CO-Fc, and the concentration used in these
experiments was based on the western blot that estimated the concentration of the
total Fc recombinant proteins in CO-Fc to the concentration of either C-Fc or O-Fc
single recombinantproteins (figure 4.18 a, b).
E8 chick forebrain neurons were stained with single recombinant chimeric
proteins; CEPU-Fc and OBCAM-Fc (10ug/ml) (control), CEPU-Fc wasbrighter than
OBCAM-Fc(figure 6.1). In figure 6.2, CO-Fe heterodimeric boundto the surface of
E8 chick forebrain neurons when live stained with CO-Fc using mouse anti-myc
antibody to detect the myc tag on the CO-Fc heterodimer complex. The single
standard chimeric protein, CEPU-Fc and OBCAM-Fcweretested by live staining of
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E10 dorsal root ganglion and sympathetic chain neurons, there was staining with
CEPU-Fcusing anti-human Fc fluorescent labelled antibody (figure6.3a), whereas no
staining occurred with OBCAM-Fc(figure6.3b). Interestingly, CO-Fc heterodimeric
protein (1300AU/ml) bound to small fraction of E10 dorsal root ganglion and
sympathetic chain neurons when detected with the anti-myc antibody while noglial
cells stained with CO-Fc (figure6.4) (figure 6.5).
In conclusion, CO-Fe may bind to E8 forebrain (but this is not conclusive
because O-Fe bound also). The evidence that CO-Fe binds to E10 dorsal root
ganglion and E10 sympathetic neurons is stronger e, while OO-Fe did not bind to
E10 dorsal ganglion neurons or sympathetic neurons.
Chick retina is a well-characterised site for expression of IgLONs, as they are
expressed in different layers of the retina. LAMP and Neurotractin are co-expressed
in both outerplexiform and inner plexiform layers, while CEPU-1 is expressed only
in the outerplexiform layer and OBCAMin the inner plexiform layerofthe retinaat
E18 age (Lodgeet al., 2000).
The retina could be an interesting site for interaction of the putative CO-Fc
heterodimer complex. In figure 6.6, the structure of the retina is described which is
formed of 10 layers comprised of different types of cells. Prefixed frozen sections of
E18 chick retina were stained with CO-Fc heterodimeric protein (1300AU/ml). The
outer plexiform and inner plexiform layers of the retina were the prominentareasfor
the binding of CO-Fc and C-Fe single recombinant protein, while O-Fc single
recombinant protein bound prominently to the outer plexiform layer of the retina
with weak bindingto the inner plexiform layer (figure 6.7).
IgLONs could be a part of the putative receptor complex for the CO-Fc
heterodimeric chimeric protein. Therefore, CEPU-CHO, OBCAM, LAMP-CHO,
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CL-CHO and CO-CHOalongside wild type CHO cells were live stained with CO-Fc
to investigate its interaction with GPI anchored IgLONs or DigLONs(figure6.8).
CO-Fc was detected by mouse anti-myc antibody and Alexa Fluor 488 secondary
antibody on the surface of IgLON transfected CHO cells except CO-CHOcells while
no staining of wild type cells was observed.
In the previous chapter, CO-Fc heterodimeric protein failed to inhibit the
neurite outgrowth from E8 forebrain neurons in the absence of IgLONsafter
successful PI-PLC treatment of E8 forebrain neurons (figure 6.9). Furthermore,
treated and untreated E8 forebrain neurons were stained with anti-CEPU, anti-
OBCAMoranti-LAMPanti-sera to ensure that no more IgLONsexist on the surface
of the neurons. Thestaining that occurred without the treatment disappeared after the
treatment with PI-PLC (figure6.8) which confirmed the removal of IgLONs from the
surface of the neurons(figure6.9). Interestingly, CO-Fe did not bind to the surface of
the neurons following treatment with PI-PLC (figure6.9). This suggested that
IgLONs, as GPI anchored proteins might be part of the putative receptor for CO-Fc
heterodimer complex.
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Fluorescence resonance energy transfer (FRET):
A key requirementto confirm the observation about CO-Fc putative binding
to forebrain neuronsis to show that the results observed are due specifically to CO-
Fc and not to OO-Fc. One methodto do this is to use FRET to distinguish between
OO-Fc and CO-Fc binding. Thefirst step is to test the fluorphors of each antibody
before FRET experiment. In figure 6.13a, LAMP CHOcells were live-stained with
CC-Fe-V5 recombinantprotein, anti-mouse anti-V5 antibody and anti-mouse Alexa
Fluor 488. Indirect immunofluorescence was used because the directly labelled anti-
V5Alexa Fluor 488 did not work properly. There is an excitation at 488nm and
emission at 520nm wavelength, but little emission at 580nm the peak of the acceptor
emission. The directly labelled mouse anti-myc Alexa Fluor 555 bound to the myc
epitope tags of OO-myc recombinant protein when used in live staining of LAMP
CHOcells. The fluorphor was excited at 488nm whereas no emission at 580nm was
observed, there was an emission at 580nm when the fluorphor excited at 560nm
(figure 6.13b). Thus, the two fluorphors were appropriate to use for FRET
experiment.
In addition, a positive control also required to ensure that the FRET technique
is going to work when used with CO-Fc recombinant protein on LAMP CHOcells.
The ratio of energy transfer will be measured between the mouse anti-myc Alexa
Fluor 555 antibody as acceptor and anti-mouse Alexa 488 antibody as donor when
bound to single OO-myc recombinant protein on LAMP CHOcells. In figure 6.14a
and b, photographs for live stained LAMP CHO cells with single OO-myc
recombinant protein that shows the emission of the acceptor (AF555) at 580nm and
emission of the donor (AF488) at 520nm before bleaching of the acceptor. The edge
of LAMP CHOcell wasselected to bleach the acceptor (green rectangular) at 60 %.
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No emission of the acceptor was detected at 580nm dueto bleaching of the acceptor,
while the donor becomes brighter than before bleaching when excited at 488nm
because the energy was emitted rather than transferred to the already bleached
acceptor (Figure 6.14c, d). In figure 6.14e, a photograph showsthe brightness of the
donor after bleaching the acceptor. The FRET ratio was variable according to the
area and the intensity of bleaching and Ro between the fluorphors. The maximum
ratio of FRET that measured between twofluorphors was about 20% in this case. In
figure 14 f, a diagram clarifies the mechanism ofthe positive control.
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DISCUSSION:
The interaction of CO-Fc heterodimeric chimeric recombinant protein with
putative receptors on the surface of forebrain and dorsal root ganglion and
sympathetic neurons can be detected either with anti-human Fe which will detect the
OO-Fc and CC-Fc beside CO-Fc. While using anti-V5 antibody will detect only CO-
Fe and CC-Fe which is known to bind strongly to neurons and its concentration is
high in the mixture of CO-Fc. The advantage of using anti-myc antibodyis that will
detect CO-Fce and OO-Fe which has weak binding to the neurons in addition to the
point that the contamination caused by OO-Fcis not abundant in the mixture of CO-
Fc. Therefore, the chance of detection of CO-Fe heterodimeric recombinantprotein
with anti-myc antibody is greater than using anti-V5 or anti-human Fe antibodies.
However, CEPU-Fcstandard chimeric protein bound to E10 DRG and sympathetic
neurons using anti-human Fe antibody while OBCAM-Fc did not, suggesting that
anti-myc was detecting the CO-Fe heterodimeric protein and not the OO-Fc
homodimeric protein.
Data so far suggests that CO-Fc binds to IgLONssince different layers of the
retina expressed different combinations of IgLONs. CO-Fc bound to the
outerplexiform layer of E18 chick retina where LAMP, CEPU-1 and Neurotractin
were expressed (Lodge et al., 2000) (Sahar Youssef PhD thesis University of
Liverpool 2007). This data suggests that there might be interactions between CO-Fc
and either LAMP, CEPU-1 or Neurotractin or combinations in the form of DigLONs.
The next experiment investigated the interaction of CO-Fc heterodimeric
protein with different IgLON transfected cell lines; CEPU-1, OBCAM, LAMP, CO,
CL or wild type CHO cells as control. This was carried out to clarify binding of
IgLONs or DigLONs with CO-Fc heterodimeric recombinant protein. There was an
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interaction between the CO-Fe with different cell lines with variable degree of
staining using anti-myc antibody. However, OO-Fc might be detected with anti-myc
as well that may explain the interaction with LAMP-CHOcells which should not
interact with CO-Fc such as LAMP-Fc that did not bind to CO-Fc CHO cells.
Surprisingly, CO-Fe did not bind to CO-CHOcells but did bind to CL-CHO cells.
This is might be due to unbalanced expression of either LAMP or CEPU-1 on the
surface of the CL-CHOcells or heterophilic interactions between DigLONs.
The loss of staining with CO-Fc heterodimeric protein due to removal of
IgLONsfrom the surface of the neurons by PI-PLC treatment supported the result in
the previous chapter, that CO-Fe did not inhibit the neurite outgrowth after the PI-
PLC treatment as before the treatment. These results suggested the idea that IgLONs
has a role in the formation of the putative receptor either alone or forming a complex
with a transmembranereceptor.
The previous data suggested that CO-Fc interacts with putative receptors on
the surface of the neurons. IgLONcould be a part of this receptor. However, IgLONs
do not have a cytoplasmic domain. Thus, IgLON plus a transmembrane receptor
could form the putative complex receptors for the CO-Fc heterodimeric chimeric
recombinantprotein.
The presence of OO-Fc may interfere with these results making their
interpretation difficult; therefore, we considered alternative ways of detecting CO-Fc
binding alone.
The experiments also confirm that Alexa 488 and Alexa555 are suitable
fluorphors for FRET andthat direct labelling of the myc and V5 tags on CO-Fe with
these fluorphor coupled antibodies should allow the measurement of FRET between
them.It is unlikely that the indirectly labelled tags will result in the fluorphors being
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close enough for FRET. Hence,it will be necessary to ensure that an anti-V5 Alexa
Fluor 488 is obtained that labels CO-Fc directly. Completion of these experiments on
forebrain neuronsandretina will provide final confirmation that CO-Fc can bind to
the surface of neurons
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Figure 6.1: E8 Forebrain neurons stained with CEPU-Fc and
OBCAM.-Fcsingle standard chimeric proteins
E8 chick Forebrain neurons were stained with CEPU-Fc and OBCAM-Fcsingle
standard chimeric proteins (10ug/ml). Antihuman Fc fluorescent labelled antibody
(1.5mg/ml) (1:100) was used as secondary antibody. CEPU-Fc stained relatively
brighter than OBCAM-FC. There was no staining in the negative control (Scale bar
SOum).
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Figure 6.2: CO-Fc binds to E8 Forebrain neuron
A subset of E8 chick forebrain neurons were stained with CO-Fc heterodimeric
chimeric protein (1333AU/ml). Primary mouse anti-myc (Img/ml) (1:50) was used to
detect CO-Fc and secondary antimouse Alexa Fluor 488 antibody (1:200). Cell
bodies, axons and dendrites were stained (scale bar5Oum).
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 Figure 6.3.: E10 DRG stained with C-Fc and OB-Fc standard
chimeric protein
E10 Dorsal root ganglion neurons were stained with CEPU-Fc standard single
IgLON chimeric protein (10ug/ml) and OBCAM-Fc standard IgLON chimeric
protein (1Oug/ml). Secondary anti-human Fc fluorescent-labelled antibody at
(1:100) was used. The neurons were stained with CEPU-Fc but not OBCAM-Fc.
(SOum scale bar).
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Figure 6.4: CO-Fc binds to E10 dorsal root ganglion (DRG)
CO-Fc heterodimeric chimeric recombinant protein (1300AU/ml) was used to stain
E10 chick dorsal root ganglion neurons. Mouse anti-myc antibody as primary
antibody (1:50), and secondary antimouse Alexa Fluor 488a antibody (1:200) were
used. Both cell body and axon were stained (10um scale bar).No staining in negative
control (SOum scale bar).
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Figure 6.5: CO-Fc binds to E10 Sympathetic chain neurons
 
Photographs (phase and fluorescence) for E10 chick sympathetic neurons, all the
neurons in the field were stained with CO-Fc protein (1300AU/ml) and primary
mouse antimyc antibody (Img/ml) (1:50), then secondary antimouse Alexa Fluor 488
(1:200). Both cell body and axons were stained. There was no staining in negative
control (Scale bar 50um).
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Figure 6.6: The structure of the retina
diagram and H&Estain cross section describes the structure of the retina whichis
composedofthe pigmentedepithelium, outerplexiform layer which contains rods and
cons, Muller cells, horizontal cells, bipolar cells, amacrine cells, ganglion cells,
nervefibre layer and inner plexiform layer.
162
 
Figure 6.7: CO-Fc bindsto the outerplexiform layer of the retina
E18 chick retina frozen section photographs (phase and fluorescence) which was
stained with the CO-Fc heterodimeric protein (1333AU/ml) using mouse antimyc
antibody (1:50) and antimouse Alexa Fluor 488 antibody (1:200). CO-Fc binds to
the outerplexiform layer and inner plexiform layer (OPL, IPL) of the retina, as
CEPU-Fc (10ug/ml), while OBCAM-Fc (10ug/ml) stained outerplexiform layer and
faint staining in inner plexiform layer. Secondary anti-Fc fluorescent-labelled was
used with single IgLON recombinantproteins (1:100).
Fluorescence photographs show no staining for a negative control using antimyc
antibody (1:50) and antimouse Alexa Fluor 488 antibody (1:200 (50um scale bar).
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Figure 6.8: CO-Fc interacts with IgLONstransfectedcell lines
CO-Fc heterodimeric protein (1300AU/ml) was used to test its interaction with
different IgLON transfectedcell lines. Anti-myc was used to detect the CO-Fc onthe
surface of the transfected CHO cells (1:50). Alexa Fluor 488 used as secondary
antibody (1:200). CO-Fc binds to CEPU-CHO, OBCAM-CHO, LAMP-CHO and
CL-CHOcells, but, it does not bind to CO-CHO or wild type CHOcells (scale bar
50 um).
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Figure 6.9: Loss of binding of CO-Fc after treatment with PIPLC
E8 Forebrain neurons stained with IgLON antisera pre and post PIPLC treatment
(anti-CEPU-I1, anti-OBCAM and _anti-LAMP)) at (1:50). Alexa Fluor 488 secondary
antibody was at (1:200) used. Post PIPLC staining with IgLONantisera confirmed
that no IgLONson the surface of the neurons. At the same experiment, E8 forebrain
neurons stained with CO-Fc(1333AU/ml) after treatment with PIPLC, CO-Fc binds
to untreated neurons, but did not bind to the treated neurons with PI-PLC (scale bar
SOum).
 C-Fe OB-Fe CO-Fc
E8 Forebrain staining Faint staining Staining
E10 DRG staining Nostaining Staining
E10 Sympathetic staining Nostaining Staining
  
E18 Retina Staining OPL-IPL Staining OPL -faint Staining OPL-IPL
IPL
CEPU-CHO Staining staining staining
OBCAM-CHO Staining Faint staining staining
LAMP-CHO Staining Staining staining
CL-CHO N/A N/A Few cell stained
CO-CHO Nostaining Nostaining Nostaining
WT-CHO Nostaining Nostaining Nostaining   Table6.10: summarytable for interactions of CO-Fc in comparison
to C-Fc and OB-Fc
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Figure 6.11: The method of Fluorescence resonance energy transfer
(FRET):
A) A diagram describes the relation between the fluorescence intensity and the
wavelength and excitation and the emission of the donor which overlapping with
excitation of the acceptor. There will be an energy transfer between the donor and
the acceptor (FRET).
B) Accurverepresents the Ro for Alexa Four 488 and Alexa Fluor 555 at which 50% of
energy transfer at 70Athat is equal 7nm.
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         ‘igure 6.12: The proposal of FRET in case of CO-Fc or mixture of|
C-V5 and O-myc recombinantproteins:
A) Before bleaching the acceptor, when the donoris excited at 488nm, 50% of
the energy will emit at 520nm and 50% will transferred to the acceptor in
case of CO-Fc heterodimeric recombinant protein at close proximity. While
in case of the mixture of CC-Fc-V5 and OO-Fc-myc, 100% of energy will
emits at 520nm.
B) After Bleaching of the acceptor, 50% of energy will emits at 520nm plus 50%
that was going to be transferred to the acceptor but due to bleaching which
will lead to increase the brightness of donor more than before bleaching.
While in case of the mixture the emission is equal to the emission before
bleaching.
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Figure 6.13: Testing the fluorphorsof the antibodies:
A) LAMP CHO cells were live stained with CC-V5 recombinant protein,
follwoed by mouse anti-V5 antibody (Invitrogen) (1:50) and anti-mouse Alexa
Fluor 488 (1:200). There is emission at 520nm following excitation at 488nm
and no emission at 580nm.
B) LAMP CHOcells were stained with transient OO-myc single transfection
recombinant protein, mouse anti-myc antibody Alexa Fluor555 (Millipore)
(1:250). No emission occured at 580nm, when the acceptor was excited at
488nm. While there was an emission at 580nm whenthe acceptor excited at
560nm.
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Figure 6.14: Positive control for FRET experiment:
  
 
LAMP CHO cells live stained with transient OO-myc_ single transfection
recombinant protein, mouse anti-myc Alexa Fluor 555 (Millipore) (1:250) and
antimouse Alexa Fluor 488 (Invitrogen) (1:200). (A)The acceptor was excited at
560nm and the donor (AF488) excited at 488nm before bleaching (B). A bright area
at the edge of the LAMP CHOcell was selected (green square) to be bleached at
60%. (C)The selected bleached area becomes darker due to the bleaching of the
acceptor whereas the donor becomes brighter after bleaching (D). An image shows
the corresponding area for FRET (E). A diagram describes the mechanism of
interaction between the donor and acceptorat close proximity when bind to OO-myc
recombinant protein on LAMP-CHOcells (E)
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Chapter Seven
Final Discussion
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DISCUSSION:
CO-Fc heterodimeric recombinant protein (DigLON-Fc) was preparedas a tool
in the investigation of the interaction of IgLONs/DigLONsandin the identification
of the putative receptors. All previous results suggested the role of CO-DigLON,was
to inhibit neurite outgrowth from a subpopulation of E8 forebrain neurons (Christine
McNamee PhDthesis, University of Liverpool 2008). CO-transfected cell line also
inhibited neurite outgrowth from cerebellar granule cells (Reed et al., 2004). In
addition, previous evidence of GP55 chick glycoprotein that has a mixture of
IgLONsinhibits the neurite outgrowth while no inhibition occurs with single IgLON
(Clarke and Moss, 1994, 1997; McNameeetal., 2002), which suggests heterodimeric
combination of IgLONs (DigLONs)is required (Reedet al., 2004).
CO-Fc heterodimeric recombinantprotein is secreted as a physical dimer, held
together by human Fctail and tagged with epitope myc and V5 tags. These tags
were used in characterisation of the complex. CO-Fc can be used as tool in
identification of the putative receptor, by testing the activity and the binding of CO-
Fc on PI-PLC treated and untreated neurons. In addition, the concentration of CO-Fc
recombinant protein can be manipulated, whereas it is difficult to estimate the
concentration of CO-DigLONthat is expressed on the surface of CO-CHOcellline.
CEPU-1 and OBCAMexist in close proximity in the CO-Fe complex, while on the
surface of CHO cells the CEPU and OBCAM mayreversibly dissociate and it may
be hard to isolate the released complex.
Although there is evidence of DigLON formation in vitro, co-expression of
two of more membersof the family in the same cells is necessary for DigLONs to
havea role in vivo. Co expression of both CEPU-1 and OBCAM protein in different
area of the nervous system suggests the formation of CO-DigLON mayoccurin vivo
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and they may have role in the development of the nervous system. E8 optic fibre
layer of chick retina is an area where both molecules are co-expressed, also cerebral
cortex, retina and hippocampus(Gilet al., 2002; Miyata et al., 2003b; Struyket al.,
1995). In contrast, CEPU-1 expressed on the outer plexiform layer whereas OBCAM
expressed in inner plexiform layer of E18 chick retina. Furthermore, double
immunofluorescence and confocal microscopy studies suggest colocalisation of two
members of IgLONs in the plane of the membrane of subpopulation of forebrain
neurons (Sahar Youssef PhD thesis, University of Liverpool 2007) (Manuscript in
preparation).
CO-Fc heterodimeric recombinant protein was produced from CHOstablecell
line, which was transfected with both pcDNA6-CEPU-Fc-V5 and pBudCE4.1-
OBCAM-Fc-mycconstructs. These epitope tags were useful for characterisation and
detection of the CO-Fc heterodimer complex. ELISA assays revealed that the cell
line produced a mixture of CO-Fc heterodimeric protein, OO-Fe and CC-Fc
homodimeric proteins. Therefore, anti-V5 and anti-myc affinity columns weretested
for their ability to purify the CO-Fe from OO-Fce and CC-Fc. Anti-myc antibody was
used to detect the CO-Fc because Thefailure of both anti-myc and anti-V5 columns
to purify the CO-Fc totally from either C-Fe or O-Fc.
The first set of experiments was designed to test whether CO-Fc had the same
activity as CO expressed together on CHOcells. CO-Fc inhibits the initiation of
neurite outgrowth from E8 forebrain neurons in keeping with results with the CO-
transfected CHOcell line, since no inhibitory activity occurred when CEPU-1 and
OBCAM single recombinant proteins were mixed together (Michael Lyons).
Therefore, CEPU-1 and OBCAM becomeactive only when acting as a heterodimer
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complex which suggests that CO-Fc will be a good tool to investigate binding to the
receptor complex.
GP55 which may contain DigLONsinhibits the neurite outgrowth of DRG
neurons (Clarke and Moss, 1994). However, CO CHO cell line and CO-Fc
recombinant protein at (7OOAU/ml) failed to inhibit the outgrowth from E10 DRG
and sympathetic neurons. Surprisingly, a high concentration of CO-Fe (2700AU/ml)
significantly inhibits the initiation of outgrowth from essentially all DRG and
sympathetic neurons. This suggests that the result might be due to the heterogeneity
between forebrain, dorsal root ganglion and sympathetic neurons.
Having established that CO-Fc has the expected activity and must therefore
interact with the surface of neurons, the binding properties were investigated. Since
CEPU-Fc binds more strongly than OBCAM-Fc,anti-myc antibody wasusedrather
than anti-V5 antibody in detection of CO-Fc heterodimeric protein in
immunofluorescence binding assays. Different IgLON-transfected cell lines were
used to test the interaction of CO-Fe heterodimeric recombinant protein. CO-Fc
bound to CEPU-CHO, OBCAM-CHO and surprisingly to LAMP CHO cells,
because LAMP-Fcdid not bind to CO-CHOcells previously. However, a low level
of OO-Fce homdimeric protein was present with CO-Fc heterodimeric protein after
purification, and may haveinterfered and been detected with the anti-myc antibody
in binding experiments.Interestingly, CO-Fc bound to CL-CHOcells and not to CO-
CHO or Wt CHOcells suggesting that heterophilic interactions may be possible
between DigLONs or CO-Fe may be binding to monomers or homodimers due to
unbalanced expression of CEPU-1 or LAMP on the surface of CHO cells. The
binding was significantly less than for the corresponding singly transfected CHO
cells.
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Since it proved difficult if not impossible to isolate CO-Fc from the OO-Fc and
CC-Fe, it might have been a better idea to label CEPU-Fc with RFP (CEPU-Fc-RFP)
and OBCAM-Fc with GFP (OBCAM-Fc-GFP). Then Fluorescence resonance energy
transfer technique (FRET) can be carried out between the GFP of OBCAM-Fc-GFP
chain and RFP of CEPU-Fc-RFP chain to distinguish between the binding of CO-Fc
heterodimeric protein from the contamination that caused by OO-Fc and CC-Fc
homodimeric recombinant proteins. However, a problem might be that protein A
would no longer bind to the Fc-GFP or RFP and purification from media might have
been difficult.
Alternatively, FRETisstill a possible option between V5 and mycepitope tags
on the CO-Fc complex, which is located at close proximity using anti-V5 Alexa
Fluor 488 antibody as a donor, and anti-myc Alexa Fluor 555 as acceptor. Single
transient transfection of CEPU-Fc-V5, OBCAM-Fc-myc and a mixture of both were
prepared for this experiment. In the case of CO-Fc, an energy transfer between can
occur between two fluorphors while no transfer is expected in CC-Fe and OO-Fc,
these are important controls as CC-Fe and OO-Fe will bind to IgLONspotentially
within lipid raft and hence will be in reasonably close proximity.
There are several examples for interactions between molecules belong to Ig
superfamily that share in formation of receptor complex and guidance molecules. An
interaction between Slit axon guidance molecule and its receptor Robo molecule
leads to guiding axons across the midline (Long et al., 2004). In addition, Netrin
plays a role in attraction of commissural axons toward the floorplate by interacting
with its receptors DCC and UNC-5 (Keleman and Dickson, 2001). The neurite
outgrowth is stimulated by interaction between netrin and DCC receptor only,
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however, when a receptor complex formed dueto cis interaction between UNC-5 and
DCC,netrin becomesinhibitor to the neurite outgrowth (Honget al., 1999).
As the putative receptors for Ig_LONs/DigLONsare not yet known,there are
different proposed options for the nature of these receptors. The first option is that
IgLONs/DigLONssignal to the cytoskeleton without the transmembrane receptor
which could be by endocytosis such as T-lymphocyte activation (discussed later).
Secondly, IgLONs/DigLONs maybind to a transmembranereceptor alone (with no
interaction in cis to IgLONs) which signals through a cytoplasmic domain. Thelast
option is that IgLONs interact with a transmembrane receptor in order to form a
receptor complex to initiate signalling pathway. For example, neuroplastin-55
induces the neurite outgrowth through binding to and activation of FGFRI
(Owczareket al., 2009). In Drosophila, amalgam is a three Ig domain secreted CAM
which signals through interaction with neurotactin transmembrane receptor (Liebl et
al., 2003). Cripto-1 is GPI- anchored protein that could be associated with a
transmembrane receptor to activate signalling pathway for
Nodal/ALK4/ALK7/Smad-2 and a Glypican-1/c-Src/MAPK/AKT (Hendrix et al.,
2007; Strizzi et al., 2005)
To investigate the role of IgLONsin formation of the receptors, the binding of
CO-Fe heterodimeric recombinant protein was tested in the presence of the
IgLONs/DigLONs on the surface of the forebrain neurons and after removal of
IgLONs by PI-PLC treatment which cleaves the GPI-anchored proteins from the
lipid rafts of the cell membrane. The findings of this experiment suggested that
IgLONs/DigLONsplay a role in formation of the putative receptors. Because the
inhibition caused by the CO-Fc heterodimeric recombinantprotein was reversedafter
PI-PLC treatmentof the neurons, this supports the hypothesis that IgLONs/DigLONs
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act as receptor, although it is still unclear whether a transmembrane receptor is
required for signaling or IgLONsinitiate the signalling pathway (figure 7.1). As a
conclusion, IgLONs/DigLONs mayhavea role in formation of the putative receptor
complex for CO-Fc heterodimeric recombinant protein whenacts as ligand. Once the
CO-Fcinteracts in trans with Ig_LON/DigLONassurface receptor.
ROCKis a part of the Rho kinase signalling pathway; it was inhibited by
Y27632 (specific inhibitor) when added to the CO forebrain culture which reversed
the inhibitory activity of CO on neurite outgrowth (Christine McNamee PhDthesis,
University of Liverpool 2008). This suggests that IgLONs/DigLONs with other
guidance molecules maysignal to the cytoskeleton of the growth cone during axonal
guidance through members of the Rho family. They are considered as GTPases and
involve Rho guanine exchange factors (GEFs) and guanine activating protein (GAPs)
which are responsiblefor initiation of the signals through Rho, Cdc 42 and Rac to the
cytoskeleton (Huberet al., 2003).
In summary, CO-Fc heterodimeric recombinant protein inhibits the initiation
of neurite outgrowth from E8 forebrain neurons as the CO-transfected cell line
(Christine McNamee PhDthesis, University of Liverpool 2008). In addition, CO-Fc
inhibits the outgrowth from E10 DRG and sympathetic chain neurons compatible
with the evidence that GP55 which may contains DigLONsand inhibits the neurite
outgrowth from DRG neurons (Moss and Clarke, 1994). In contrast, the CO-
transfected cell line and CO-Fc at low concentration fail to inhibit.
IgLONs may be part of the putative receptor for CO-Fe heterodimeric
recombinantprotein. This was revealed from PI-PLCtreated and untreated forebrain
neurite outgrowth assay and immunofluorescence studies. In particularly, CO-Fe
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binds to the IgLON-transfected CHO cell lines; CEPU-1, OBCAM, LAMP and
interestingly CL and not CO-CHOcell lines which suggests that the putative receptor
for CO-Fe could be (CL) DigLONsor single IgLONs. A transmembrane receptor
may berequired to initiate the signalling pathway but this needs further investigation.
Interestingly, activation of T-cell lymphocyte by crosslinking of different GPI-
anchored proteins such as CD48 suggested that signaling transduction through GPI
anchored protein might be possible (Ilangumaran et al., 2000; Robinson, 1991). In
addition, interleukin-18 (IL-18) binds to CD48 GPI anchored protein beside IL-18
receptor result in stimulation of T-cells and natural killer (NK) cells to produce
interferon-gamma (Fukushimaet al., 2005). The production of interferon-gamma
was inhibited by PI-PLC treatment of these cells which supports the involvement of
CD48in signaling process (Fukushimaet al., 2005).
Endocytosis of GPlI-anchored proteins are considered to be a possible
mechanism of signaling of GPI-anchored proteins, which are distinguished from
those signal through transmembrane proteins which thought to be internalised
through clathrin-coated vesicles(Bamezai et al., 1992; Bamezai and Rock, 1991;
Deckert et al., 1996; Keller et al., 1992). The folate binds to a GPI-anchoredfolate
receptor on the surface of MA104 cells, and then the complex moves into the
intracellular compartment in intracellular endosomal compartments. The ligand
remains in the intracellular compartment and free receptors move backto the cell
surface (Kamenetal., 1988). Folate internalisation by cells that express constructed
chimeric folate receptors that have a transmembrane receptor with transmembrane
domains instead of GPI-anchors via clathrin-coated vesicles is less efficient than
those expressing receptors with GPI-anchored folate receptors (Ritter et al., 1995).
There is a contradiction between endocytosis of folate-receptor GPI-anchored
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proteins (FR-GPI) and prion proteins, which are cell surface proteins and showsrole
of clathrin-coated vesicles (Sabharanjak et al., 2002). There is role for sphingolipids
and cholesterol in GPI-anchored protein endocytosis. Endocytosis of urokinase-type
plasminogen activator receptor (uPAR) required interaction with transmembrane
receptor such as LDL-receptor related protein (LRP (Czekayet al., 2001). FRET
analysis revealed that uPAR exists in either dimeric or monomeric formsin the basal
membrane (Figure 7.2) (Caiolfa et al., 2007).
A large number of GPI-anchoredprotein are able to activate signaling pathway
despite the lack of transmembrane or cytoplasmic domains (Robinson, 1991). Signal
transduction due to phosphorylation of tyrosine residue of intracellular substrates by
cross linking of GPI-anchored proteins (Brown and Cooper, 1996). CAECAM6is an
example for GPlI-anchored protein that may manipulate intracellular signal
transduction; however, the mechanism is not clear. Activation of c-Src by cross-
linking of CAECAM6is associated with phosphorylation of FAK (Duxburyetal.,
2004). Thy-1 is GPlI-anchored protein that inhibits the neurite outgrowth over
astrocytes, replacement of its GPI-anchor with a transmembrane domain of CD8 or
NCAMreversethe inhibitory action. This suggests the importance of the GPI anchor
in locating specific proteins in lipid rafts and in contact with other signaling partners
such as SFK (Kasahara and Sanai, 2000; Regeet al., 2006; Tiveronet al., 1994). In
addition, Thy-1 is required for fibroblast migration which induced by TSP-I/hep I
interaction which lead to FAK phosphorylation (Figure 7.3) (Rege et al., 2006).
So far all the evidence for DigLONs have been obtained by our group until
recently, key functional data on the role of IgLONs in synapse formation has been
obtained which supports the hypothesis that IgLONs act as heterodimeric complexes
(DigLONs) (Hashimoto et al., 2009; Reed et al., 2004). There was a significant
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reduction in the number of synapses occurring due to double overexpression of Ntm
(CEPU-1) and OBCAM in hippocampal neurons, while single overexpression of
OBCAM caused significant increase of synaptic number, whereas no change
occurred with overexpression of single Ntm (CEPU-1). In addition, overexpression
of kilon-Ntm, kilon-OBCAM or LAMP-Ntm caused reduction in synaptic number.
Surprisingly, LAMP-OBCAM had no effect on the number of synapses. This
suggests the crucial role of IgLON-IgLON cis homophilic and_heterophilic
interactions at pre and post synaptic sites (Hashimotoet al., 2009).
ELISAassays revealed that CHOstable cell line secreted a mixture of CO-Fc,
CC-Fe and OO-Fc. CO-Fe was not fully purified by affinity columns. Therefore,
FRETis required to distinguish the CO-Fc heterodimeric recombinant protein from
the CC-Fc and OO-Fe homodimeric recombinant protein using anti-V5 Alexa Fluor
488 and anti-myc Alexa Fluor 555 antibodies. Preliminary FRET experiments were
carried out to generate a positive control and testing the two fluorphors.
In parallel to preparation of CO-Fc heterodimeric protein, I have generated
pBudCE4.1-LAMP-Fc-myc construct which was used alongside peDNA6-CEPU-Fc-
V5 construct in generation of CEPU-LAMP-Fc stable CHO cell line (CL-Fc).
However, due to lack of time, I have concentrated on investigation of activity and
interactions of CO-Fc heterodimeric recombinantprotein.
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(A) (B)
CO-Fe CO-Fe
OR
IgLON or DigLON IgLON +Transmembranereceptor
Cell membrane Cytoplasmic domainj
Signal to Cytoskeleton
Figure 7.1: the proposed options for the putative receptor for CO-Fc
complex androle of IgLONs
There are two proposed options for the putative receptor for CO-Fc heterodimeric
recombinantprotein that are suggested by the evidencesin this thesis
A) CO-Fc binds to IgLONs or DigLONson the surface of the growth cone and
initiate signalling pathwayto the cytoskeleton of the growth cone.
B) CO-Fc binds to a receptor complex formed by IgLON and transmembrane
receptor with cytoplasmic domain which initiate the signal pathway to the
cytoskeleton.
In both options, IgLONhasa role in the formation of the putative CO-Fc receptor.
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Figure 7.2: Endocytosis of GPI-anchored protein mechanisms:
An illustration describes the mechanism of endocytosis of GPI-anchored proteins.
Different GPI-anchored proteins distributed on the cell membrane (A). The
interaction GPI anchored proteins (FR-GPI) (blue), uPAR (red) or prion (yellow)
with a transmembrane receptor (LRP) (green). The sphingolipids and cholesterol in
the lipid are essential for these interactions (B). There are two ways of endocytosis;
CD42 endocytosed into tubular invagination to form GPI-AP enriched endosomal
compartments (GEECs), or LRP-GPI-anchored protein complex was endocytosis in
clathrin-coated pits(C, D) (Lakhan et al., 2009).
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Figure 7.3: Modulation of FAK signaling pathway by GPI-anchored
proteins:
A schematic diagram describes the effect of Thy-1 (GPlI-anchored protein) on
signaling of TSP/hep I. This interaction lead to recruitment of SFK and FAKto the
lipid raft, and then initiate the downstream signaling pathway such as PI 3-kinase
and ERK which result in focal adhesion assembly and migration offibroblast (Rege
et al., 2006).
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